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ABSTRACT

VASCULAR CELL DYSFUNCTION AND TRANSENDOTHELIAL MIGRATION
OF NEUTROPHILS IN PREECLAMPSIA
By Courtney E. Leik, Ph.D.
A dissertation submitted in partial fulfillment ofthe requirements for the degree of
Doctor ofPhilosophy at Virginia Commonwealth University
Virginia Commonwealth University, 2003
Director:

Dr. Scott W. Walsh
Professor
Departments ofObstetrics and Gynecology, and Physiology

Oxidative stress, hyperlipidemia, neutrophil activation and endothelial cell
dysfunction are characteristic of women with preeclampsia We used in vitro experiments
to test ifa combination ofoxidative stress and linoleic acid favors a mechanism for
neutrophil transendothelial migration. We used linoleic acid because it is one of the fatty
acids elevated in preeclampsia and the precursor for arachidonic acid and its
inflammatory metaboli!es. For these studies, we developed a methodology for isolating
and culturing human vascular smooth muscle cells from placental chorionic plate arteries.
Treatment ofthese cells with an oxidizing solution enriched with linoleic acid, but neither

xviii
component alone, led to increased production of interleukin-8 (IL-8), a potent neutrophil
chemotactic agent. This treatment solution also stimulated arachidonic acid metabolites,
including leukotriene B4, another potent neutrophil chemotactic agent. The same
treatment solution rapidly activated neutrophils to produce superoxide. These
observations suggested there might be neutrophil transendothelial migration in women
with preeclampsia because increased expression of IL-8 by vascular smooth muscle
would attract neutrophils to the vasculature, and activation ofneutrophils would prime
them for transendothelial migration. These predictions were confirmed using
immunohistochemical staining ofsystemic vascular tissue in preeclamptic women, as
compared to normal pregnant and normal non-pregnant women, by demonstrating
vascular smooth muscle cell expression ofIL-8 coincident with neutrophil infiltration
into systemic vessels. Endothelial cells and vascular smooth muscle cells also expressed
ICAM-1, a cell adhesion molecule necessary for neutrophil infiltration.
This investigation is the first to demonstrate vascular smooth muscle cell
expression of IL-8 and ICAM-1 coincident with neutrophil transendothelial migration
into systemic vascular tissue in women with preeclampsia. These observations provide
evidence for total "vascular cell dysfunction", not only endothelial cell dysfunction, in
women with preeclampsia. Together they link vascular cell dysfunction to a single
mechanism, transendothelial migration ofneutrophils, which could explain the clinical
symptoms of hypertension, proteinuria, and pathological edema. These results bolster the
use ofantioxidants in preventipg preeclampsia and suggest novel treatments for
preeclampsia based on neutralizing antibodies to IL-8 or cell adhesion molecules.

Chapter 1

GENERAL INTRODUCTION

A. Introduction

Preeclampsia is a significant pregnancy-related disorder that affects 6-8% of all
human pregnancies and is the leading cause of intrauterine growth retardation (IUGR),
premature delivery, and maternal death 1 . It is a multi-system disorder clinically
characterized by maternal hypertension � 140/90 mm Hg), proteinuria (> 300 mg/24
hours), pathological edema, and coagulation abnormalities. There is also evidence of
compromised uteroplacental, fetoplacental, and maternal organ perfusion in preeclamptic
women. Although preeclampsia does not present clinically until the second or third
trimesters of pregnancy, the pathological process is believed to begin at placentation.
A working hypothesis for the pathophysiology of preeclampsia states that the
2
disorder has two stages . The first stage is the initiation of the pathophysiological
process caused by abnormal placental implantation, which leads to reduced placental
blood perfusion. The second stage is characterized by maternal endothelial cell
dysfunction and subsequent clinical symptoms. The link between the first and second
stage is not clear, although it is hypothesized that abnormal placentation results in the
1

2
release of toxic agents that enter the maternal circulation, causing endothelial cell
dysfunction. The clinical manifestation and progression of preeclampsia depends on the
mother's pre-disposing circulatory health 3 .
Research supports the belief that oxidative stress links the two stages of
preeclampsia. Evidence confirms oxidative stress in the placenta and maternal circulation
and suggests agents that could transfer oxidative stress between the two compartments.
This literature review will summarize the current understanding of the role of oxidative
stress in the pathogenesis of preeclampsia, with a focus on maternal vascular smooth
muscle, endothelial, and neutrophil dysfunction. First, a general review of free radical
and antioxidant biochemistry is essential to understanding the relationship between
oxidative stress and preeclampsia.

B. Free Radicals, Antioxidants, and Oxidative Stress

Multicellular organisms require oxy gen for the efficient production of energy.
Oxy gen, however, is a toxic gas. Over the past 50 years it has become evident that
oxy gen mediates toxic effects through the production of free radical species. A free
radical, as defined by Halliwell, is "any species capable of independent existence that
contains one or more unpaired electrons"

4

.

Free radicals are highly reactive species

because they will attack nearby atoms or molecules for electrons to complete their outer
electron orbital and, therefore, restore their stability.

Approximately 1 -3 % of inhaled oxygen forms free radicals 5 . The body produces
free radicals spontaneously and deliberately during chemical reactions. Reactive oxygen
species (ROS) are natural byproducts of oxidative metabolism. During oxidative
metabolism, electrons flow through a series of electron carriers, eventually to the final
electron carrier of cytochrome oxidase, which reduces oxygen to water. A small
percentage of electrons leak from the electron transport chain and combine with oxygen
to produce the free radical, superoxide (02.) 5 •
Oxidase enzymes also yield ROS byproducts. For example, xanthine oxidase
spontaneously produces 02 ·- during purine base catabolism, while cyclooxygenase
(COX) and lipoxygenase (LPO) produce ROS during arachidonic acid (AA) metabolism
6

•

An oxidase enzyme that deliberately produces ROS is the nicotinamide-adenine

dinucleotide phosphate (NADPH) oxidase of neutrophils. Upon neutrophil activation,
NADPH oxidase incorporates into the cell membrane and reduces molecular oxygen to
02·-, which leads to the formation of ROS for the destruction of bacteria and other
pathogens. NADPH oxidase also was localized recently to endothelial and vascular
smooth muscle cells, where ROS may play a role in cell signaling 7 •
ROS is a collective term that encompasses oxygen radicals and non-radicals.
Many ROS are pro-oxidants, agents that oxidize various targets by removing electrons or
hydrogen, or by adding oxygen 4 . The "reactive" in ROS is relative since their reactivity
varies depending on environmental conditions 4 . 02·- is an important oxygen free radical
produced when diatomic oxygen accepts an extra electron (Table 1 ). It is not particularly
reactive alone, but in the presence of transition metals and/or other ROS, highly toxic

4
species are produced. For example, 0/- reacts with transition metals to form the highly
reactive hydroxyl radical (OH•). H202 , a non-radical derivative ofoxygen, also produces
the OH• by a metal-catalyzed reaction.
Reactive nitrogen species (RNS) are a recent addition to free radical biochemistry.
Nitric oxide (NO') is the most commonly known RNS. NO" is a free radical with a single
unpaired electron formed in the conversion of L-arginine to L-citrulline by nitric oxide
synthase (NOS) 4 . Similar to 0/-, NO" is not a very reactive free radical and actually has
a more important physiological role (i.e. vasodilatation) than pathological role 4 . No· can,
however, react with 02 ·- to produce the strong oxidizing agent, peroxynitrite (ONOO-)
(Table 1). ONOO- formation occurs three times faster than the dismutation of 02·- to
H202 8 .
Since oxidative metabolism and other physiological processes produce free
radicals, mechanisms are necessary to inhibit free radical damage and maintain oxidant
antioxidant balance. Endogenous antioxidant defense mechanisms are either enzymatic or
nonenzymatic. The three most important cellular antioxidant enzymes are superoxide
dismutase (SOD), catalase, and glutathione peroxidase (Table 2). They function together
to eliminate ROS generated during oxidative metabolism, which can damage cellular
membranes, proteins, and DNA (Figure 1). SOD dismutates 02 ·- to H 202 and molecular
oxygen. Thus, it is a significant antioxidant enzyme because it quenches 02·- produced
during oxidative metabolism. Cellular SOD exists in two forms; copper zinc SOD is
located in the cytosol while manganese SOD is located in the mitochondria. (There is
also an extracellular SOD, which functions to minimize oxidative stress in the plasma.)

5
Catalase is located in the cytosol and functions in conjunction with SOD to catalyze the
conversion ofH202 to water and molecular oxygen. Glutathione peroxidase is a selenium
dependent enzyme that is similar to catalase in that it catalyzes the reduction of H202 to
water and molecular oxygen. Selenium-dependent glutathione peroxidase, however,
unlike catalase, also reduces free lipid peroxides to nonreactive fatty acid alcohols

9.

Selenium-dependent glutathione peroxidase resides in the cytosol. A second form of
glutathione peroxidase, phospholipid hydroperoxide glutathione peroxide, is located in
the cell membrane and acts on membrane-bound lipid peroxides

10 .

This form is also

selenium-dependent.
Nonenzymatic antioxidants can be divided into a fat-soluble group and a water
soluble group 4 . For example, vitamin E is a fat-soluble vitamin composed oftocopherols.
Of these, d-a-tocopherol has the greatest biological activity

1 1.

Vitamin E is found in cell

membranes and functions as a chain-breaking antioxidant to inhibit lipid peroxidation 9•
1

1.

Vitamin E also modulates redox cell signaling pathways to prevent free radical

damage

11

.

In the process of inhibiting lipid peroxidation, vitamin E becomes a radical

and must be recycled (reduced) by vitamin C

5.

Other lipid soluble antioxidants include:

carotenoids (i.e. �-carotene and lycopene), flavonoids, and vitamin A

1 2.

Vitamin C (ascorbic acid) is a water-soluble chain-breaking antioxidant

1 .
3

It is

considered important for its role in recycling the vitamin E radical and in scavenging
other free radicals. Metal transport and storage proteins are also water-soluble antioxidant
defense mechanisms. These proteins bind iron and copper ions to prevent metal-catalyzed
free radical damage, lipid peroxidation, and OH• formation 9. Iron is bound to transferrin

in the plasma and to lactoferrin in body secretions

9.

6
Ceruloplasmin binds and transports

copper 9 .
Oxidative stress is a state of imbalance between ROS/RNS and antioxidant
defenses that favors ROS/RNS. This imbalance occurs when there is either a decrease in
antioxidants (enzymatic and/or dietary) or an increase in the production of free radicals.
Increased concentrations of ROS/RNS may result from: 1) excessive oxygen levels, 2)
toxins, 3) ischemia-reperfusion, 4 ) leukocyte activation, etc. 4 .
An imbalance toward reactive species leads to unchecked free radical cascades
that cause transient or permanent tissue injury. During initial periods of oxidative stress
tissues adapt and produce additional antioxidant molecules to maintain cell homeostasis.
Severe oxidative stress, however, causes irreversible cell damage that ultimately leads to
cell death. For this reason oxidative stress is a pathological mechanism of tissue injury in
a wide variety ofdiseases 9 .
Many functionally and structurally important biological molecules are targets of
oxidative stress. Consequently, oxidative stress often alters cell behavior. The effects
vary according to the cell type, the involved ROS/RNS, and the severity of the stress.
Cell functions that are affected by oxidative stress include: altered membrane function,
cell division, intercellular communication, and signal transduction 4 .
Lipids, especially polyunsaturated fatty acids (PUFAs), are often involved in
oxidative stress because they are the major constituents of biological membranes. Since
the lipid bilayer serves as a protective barrier, oxidative stress initially alters membrane
function to cause: increased fluidity, increased permeability to proteins, and inactivation

7
4
of membrane-bound enzymes . PUFAs are especially vulnerable to oxidation at carboncarbon double bonds. Initiation oflipid peroxidation occurs at fatty acid double bonds, by
a reactive species that can remove a hydrogen atom to form a lipid peroxyl radical
(Figure 2). OH• and ONOO- are primary agents of lipid peroxide initiation. Following
initiation, the lipid undergoes a molecular rearrangement to form a conjugated diene.
Propagation occurs when the lipid peroxyl radical attacks an adjacent fatty acid to form
another peroxyl radical. Lipid peroxyls and hydrogen ions then interact to produce lipid
peroxides. Another membrane lipid, AA, undergoes free radical, nonenzymatic
peroxidation to produce toxic products called isoprostanes. Isoprostanes are
prostaglandin-like compounds that mediate a variety of damaging actions, including
potent vasoconstriction.

C. Oxidative Stress in Preeclampsia

Oxidative stress occurs during normal pregnancy, but antioxidant defenses
simultaneously increase to oppose free radical activity

14

.

In preeclampsia, however, there

is greater lipid peroxidation and oxidant activity with a net decrease of antioxidants,
producing a state ofoxidative stress 14 .
The dominating hypothesis proposes that the primary pathological event of
preeclampsia is insufficient trophoblast invasion of the spiral arteries during placental
implantation 15. Incomplete spiral artery remodeling creates a vasoconstrictive placental
bed characterized by ischemia-reperfusion and the production ofROS. In the presence of

8
peroxidation.
Lipid
ROS, abundant placental PUF As serve as substrates for lipid
peroxides and ROS attack placental cell membranes to perpetuate oxidative stress and
damage. Gradually, as placental mass increases, placental oxidative stress is transferred
to the mother.
Oxidative stress appears to be the link between placental pathology and vascular
cell dysfunction in the maternal compartment, which results in the clinical manifestation
of preeclampsia The placenta intimately links and mediates exchange between two
genetically distinct organisms, the mother and the fetus. Through the placenta, the
maternal system maintains the proper functioning and homeostasis of the fetal
compartment. Thus, oxidative stress in one compartment may alter homeostasis in
another compartment. The distinctive roles and functions of the fetal, placental, and
maternal compartment demand that each system be analyzed individually for oxidative
stress.

i. Fetal Oxidative Stress

There is little evidence for fetal oxidative stress during preeclamptic pregnancy.
The child's health during a preeclamptic pregnancy depends more upon uteroplacental
perfusion than oxidative stress within the fetal compartment 1 5 . The mechanics and innate
properties of the placenta, however, may protect the fetus from oxidative stress during
normal and preeclamptic pregnancies. This is especially important because oxidative

9
stress in the placenta is the likely origin of excessive maternal oxidative stress during
preeclarnpsia.

ii. Placental Oxidative Stress

Lipid peroxidation in the placenta during nonnal pregnancy was first described in
1979 1 6 . Approximately ten years later Wang et al. demonstrated elevated lipid peroxides
in preeclamptic placentas as compared to normal placentas by measuring
malondialdehyde (MDA) and H 202 equivalents

17

.

This initial study was followed

quickly by research demonstrating secretion oflipid peroxides predominately toward the
maternal circulation upon placental perfusion of t-butyl hydroperoxide as compared to
Krebs-Ringer bicarbonate buffer

1 8.

Simultaneous placental perfusion of aspirin blocked

the secretion of lipid peroxides, suggesting cyclooxygenase (COX) involvement. A
comprehensive follow-up study showed significantly greater lipid peroxide, thromboxane
A2 (TXA2 ) and prostacyclin h (PGh) production by trophoblast cells isolated from
preeclamptic placentas as compared to nonnal placentas

1 9.

Furthennore, villous core

tissue isolated from preeclamptic placentas produced significantly more lipid peroxides
and TXA2, but not more PGI2 , than villous core tissue of normal placentas. Additional
studies demonstrated that there is compartmentalization within the placenta: trophoblast
cells produce more lipid peroxides and TXA2, whereas vascular tissue (chorionic plate
arteries) produces more PGiz.

10

Lipid peroxides are not only a consequence ofoxidative stress, but also influence
enzyme activity to further alter the balance between oxidants and antioxidants.
Specifically, lipid peroxides stimulate COX to generate prostaglandins and
14
thromboxanes, including the vasoconstrictor TXA2 and the vasorelaxant PGii (Figure
3). Lipid peroxides, however, simultaneously inhibit the PGI2 synthase enzyme so that
PGI2 is not available to counteract the vasoconstricting actions of TXA2. Thus, elevated
lipid peroxides in preeclamptic placentas would lead to an imbalance of increased TXA2
and decreased PGii. Walsh analyzed TXA2 and PGI2 production from term placentas and
was the first to describe that preeclamptic placentas produce seven times more TXA2 than
PGI2 compared to normal placentas. This TXA2/PGI 2 imbalance could explain many
clinical findings ofpreeclampsia 20.
The generation of ROS from enzymes, cytok:ines, and biochemical processes are
sources of placental oxidative stress during preeclampsia. Preeclamptic placentas have
greater COX-2 trophoblast expression and activity, as well as increased COX- I placental
bed protein and mRNA levels 2 1 ' 22. Elevated COX-I & -2 protein levels may contribute
to placental oxidative stress by the spontaneous release of 02·- during COX activation,
while amplifying the TXA2/PGI2 imbalance due to COX activation by lipid peroxides.
The NADPH oxidase enzyme, which mediates the phagocytic respiratory burst of
leukocytes, was localized recently to endothelial and vascular smooth muscle cells 7. As
an important ROS-generating system, NADPH oxidase activation in the placenta may
cause or contribute to oxidative stress during preeclampsia. Only one study has evaluated
NADPH oxidase in preeclamptic placentas. Although NADPH oxidase staining pattern
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and intensity of synctiotrophoblast cells was equivalent in normal and preeclamptic
placentas, enzyme activity may differ and lead to greater placental oxidative stress 23 .
Cytokines, specifically TNFa, may also increase ROS by stimulating 0/
production by coenzyme Q of the electron transport chain in mitochondria of
preeclamptic placentas

24 .

Wang et al. found elevated TNFa mRNA and protein in

preeclamptic placentas, which indicated that TNFa was available to stimulate coenzyme
Q and result in Oi"- production 25 . The number ofmitochondria, a source ofoxygen free
radicals, was also elevated in preeclamptic placentas and may act to increase ROS 26.
ROS perpetuate oxidative stress by lipid peroxidation and isoprostane formation.
Walsh et al demonstrated both elevated lipid peroxidation and increased 8-isoprostane
release from preeclamptic placentas

1 8• 2 7 .

Superoxide is the primary agent in causing AA

peroxidation for the formation ofisoprostanes 28 . Significantly elevated protein carbonyls
in the placental and decidual tissue of preeclamptic women confirm ROS-mediated
protein damage and general placental oxidative stress 29_
In addition to attacking proteins and lipids, 02·- interacts with NO" to produce
ONOO- in the placenta. Preeclamptic placentas have evidence of this ONOO- formation.
Myatt et al. illustrated the presence of nitrotyrosine residues, the stable product of
ONOO- and protein interaction, in preeclamptic placentas by immunostaining placental
villous vascular endothelium and smooth muscle 30. Preeclamptic placentas, furthermore,
released greater concentrations of ONOO- into the maternal circulation

30

.

ONOO- action

further contributes to the feed-forward cycle of oxidative stress present in preeclamptic
placentas.

12

Placental antioxidant mechanisms oppose free radical damage in healthy

pregnancy. During normal pregnancy, placental SOD and catalase activity increase while
glutathione peroxidase activity remains steady

24 .

In preeclampsia, however, placental

antioxidant protection is decreased Preeclamptic placentas have reduced Cu-Zn SOD and
glutathione peroxidase activity and rnRNA expression 3 1 ' 32 . A recent study, however,
showed increased glutathione levels and glutathione peroxidase activity in placental and
decidual tissue from preeclamptic women

33 .

Studies performed by Poranen et al. on

preeclamptic placentas confirmed decreased SOD activity, but not decreased glutathione
peroxidase activity

34

.

Decreased SOD levels imply that Oi "- is available for longer

periods in which it can react with AA or No· to produce isoprostanes or ONOO-,
respectively. Normal and preeclamptic placentas showed similar extracellular SOD
localization and activity, indicating that extracellular SOD is probably not significant in
the pathology ofpreeclampsia 35 . Another group demonstrated, in severe preeclamptics, a
decrease of thioredoxin and glutaredoxin 36 . These antioxidant enzymes are involved in
the thiol redox control of enzymes and transcription factors that mediate transcription and
translation during oxidative stress.
The role of placental lipid- and water-soluble vitamins in preeclampsia also has
been studied. There is evidence of lower vitamin E levels in placental tissue from
preeclamptic women

31

.

Addition of vitamin E blocked peroxide-induced

vasoconstriction in a placental perfusion model

37.

Other studies confirmed the

importance ofantioxidants by perfusion ofpreeclamptic placentas with vitamins E and C
38

or � -carotene

39

to reduce lipid peroxide production. These studies suggested that
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preeclamptic placentas may have lower dietary antioxidant concentrations and, therefore,
be unable to control lipid peroxidation. Decreased antioxidant molecules and enzymes in
preeclamptic placentas may not be the cause of oxidative stress but, rather, may be the
result of oxidative stress. Whatever the case, decreased antioxidant protection would
worsen oxidative stress.
Oxidative stress may be the link between insufficient placental perfusion and
maternal endothelial cell dysfunction in preeclampsia The direct exchange between the
placenta and the maternal circulation allows for the transfer of placental oxidative stress
to the mother by lipid peroxides, ROS, circulating leukocytes, and oxidized
syncytiotrophoblast micromembrane (STBM) fragments. Although oxidative stress
originates in the placenta, it is systemic maternal oxidative stress that leads to cellular
dysfunction, which causes the clinical presentation of preeclampsia. This is discussed in
the next section.

iii. Maternal Oxidative Stress

Maternal plasma lipid peroxide levels are increased above non-pregnant levels
2
during normal pregnancy and further increased during preeclampsia 40-4 . A likely source
of elevated circulating lipid peroxides during pregnancy is the placenta

14

.

Normally

placental growth parallels a progressive rise in antioxidant defenses during pregnancy,
2
which counteracts oxidative stress produced by the placenta 4. In preeclampsia, however,
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significantly elevated lipid peroxides and decreased antioxidant mechanisms support selfpropagating lipid peroxidation and widespread cell damage.
Research has demonstrated increased serum lipid peroxides in preeclamptic
women. Maternal serum lipid peroxides, measured by the breakdown product, MDA,
were significantly elevated in mild preeclampsia and even more elevated in severe
preeclampsia compared to normal pregnancy 43• Hubel et al. demonstrated elevated levels
of serum lipid peroxides, as well as elevated levels of serum triglycerides and free fatty
acids (FFA) in women with preeclampsia. The levels significantly decreased by 24 -48
hours post-partum, implicating the placenta as the source ofthe elevated levels of lipids
44.

Other studies confirmed maternal oxidative stress with evidence of elevated

conjugated dienes, 8-isoprostanes, triglycerides, and iron levels in preeclamptic
4
individuals 2 . A recent study, which measured oxidized low density lipoproteins (LDL),
rather than lipid peroxide metabolites, did not find an increase in oxidized LDL in
preeclamptic patients 45 . These investigators suggested that secondary lipid peroxidation
products, such as aldehydes or lipid peroxide metabolites originating in the placenta,
might mediate oxidative damage in the maternal circulation in preeclampsia.
Maternal oxidative stress may be responsible for the TXA2/PGI2 imbalance that
characterizes not only the placenta, but also the systemic maternal compartment in
preeclampsia 43 • 46• 47 . Lipid peroxides secreted by the placenta could activate COX, while
inlubiting PGI 2 synthase ofendothelial cells to increase TXA2 and decrease PGI2 plasma
levels. Oxidized fatty acids may also explain increased TXA2 and decreased PGii
production by monocytes from women with preeclampsia as compared to women with

normal pregnancy

47

.
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Finally, ROS from other sources (i.e. activated leukocytes and

enzymes) would exacerbate this TXA2/PGI2 imbalance by stimulating and propagating
lipid peroxidation.
Antioxidants, the opponents of free radical cascades, are reduced in the maternal
circulation during preeclampsia. Preeclamptic women have decreased plasma levels of
2
vitamin C, vitamin E, vitamin A, {3-carotene, glutathione, and iron-binding proteins 4.
Hubel et al further demonstrated increased plasma vitamin C depletion rates, indicative
of oxidative stress, from preeclamptic women 1 5 . Moreover, early prophylactic treatment
with vitamins E and C decreased the incidence ofpreeclampsia in women at high risk 48.
This correlated with lower urinary isoprostane levels, indicating a reduction of maternal
oxidative stress, and supporting the role of oxidative stress in the pathology of
preeclampsia 49. The activity of the antioxidant enzyme, SOD, also was decreased in
erythrocytes and leukocytes 50. As in the placenta, oxidative stress propagates because
low levels of SOD allow excess 02 ·- to interact with AA and NO" to form powerful
oxidants. Furthermore, 0 2·- was shown to increase free iron levels, which leads to
accelerated cell membrane lipid peroxidation by the Fenton reaction

5 1 • 52

•

Decreased

plasma antioxidants are likely a result ofwidespread maternal oxidative stress and not the
primary stimulus for the oxidant imbalance.
These data clearly demonstrate the involvement of oxidative stress in the
pathophysiology of preeclampsia. Oxidative stress is the result of excess oxidants in the
presence of decreased antioxidants. Preexisting conditions that involve oxidative stress,
such as obesity, diabetes and hyperlipidemia, increase the risk ofpreeclampsia Since the
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balance is already tipped toward oxidative stress in the pre-partum state for these
individuals, additional lipid peroxides secreted from a growing placenta can lead to a
state ofmaternal oxidative stress by the second or third trimesters of pregnancy, resulting
in the clinical symptoms ofpreeclampsia 24(Figure 4).

D. Maternal Cell Dysfunction in Preeclampsia

Oxidative stress of the preeclamptic placenta may be transferred to the maternal
circulation by secreted lipid peroxides, ROS, cytokines, circulating leukocytes, and/or
STBM particles to induce maternal cell dysfunction in many organ systems. These
factors may influence one another to propagate oxidative stress and produce cellular
damage leading to the clinical syndrome ofpreeclampsia Next, this review will focus on
the effects of oxidative stress on vascular smooth muscle cells, endothelial cells, and
neutrophils and, finally� their linked role in the pathogenesis of preeclampsia

i. Vascular Smooth Muscle

Vascular smooth muscle is critical in mediating the normal hemodynamic changes
associated with pregnancy and the abnormal hemodynamics of preeclampsia S3. Since the
endothelium modulates vascular smooth muscle tension, most preeclampsia research has
focused on endothelial cell physiology despite the obvious role of vascular smooth
muscle in hypertension. Only recently groups have begun to investigate vascular smooth
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muscle functioning during preeclampsia. Bearchell et al. treated vascular smooth muscle
with preeclamptic serum and measured changes in vascular smooth muscle oxygen
consumption. They found an increase in oxygen consumption, which is indicative of
muscle contraction 54• Removal of preeclamptic serum returned oxygen consumption to
control levels. They hypothesized that a toxic factor might be present in preeclamptic
serum that directly alters vascular smooth muscle function. Another study demonstrated
that placental extracts from women with preeclampsia lead to increased oxygen
consumption by porcine carotid arteries as compared to placental extracts from
normotensive women. Furthermore, placental extracts from women with preeclampsia
produced greater histamine-induced vasoconstriction of these vessels than extracts from
normotensive women 55• Additional experiments indicated lipid peroxides to be the active
agents of preeclamptic placental extracts. Another group corroborated that preeclamptic
serum altered vascular smooth muscle function. Specifically, preeclamptic serum
attenuated whereas non-pregnant and normal pregnant serum augmented the intracellular
calcium response of vasoactive agents 56• Although the implications are unclear, these
data demonstrate vascular smooth muscle dysfunction in the presence of preeclamptic as
compared to normal pregnant serum factors. The studies completed so far have shown
that vascular smooth muscle function is altered in the presence of preeclamptic serum,
but they have not shown that there is specific dysfunction of vascular smooth muscle. In
Chapter 3 , we will show spe�ific and direct evidence for dysfunction of vascular smooth
muscle in preeclampsia.
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ii. Endothelium

The endothelium is a complex organ that serves as a regulator of vascular smooth
muscle tone and as a mechanical barrier to prevent blood and other circulating factors
from entering the extravascular space. Therefore, it is a source of important vascular
smooth muscle functional mediators, including PGI2, endothelin (ET), and No·.
Endothelial cells also release proteins that inhibit platelet aggregation, prevent
intravascular coagulation, and orchestrate inflammatory cell influx 57 .
During pregnancy, endothelial cell behavior is modified to satisfy the demand for
increased blood volume while maintaining lower blood pressures and reduced
vasopressor sensitivity

58

•

High blood pressure and increased vasopressor sensitivity

during preeclampsia suggest endothelial cell involvement. The original description of
"endothelial cell dysfunction" in preeclampsia combined morphological, biochemical, in
vivo and in vitro evidence

59

•

Since the hypothesis was first presented, research has

continued using techniques, such as treating cultured endothelial cells with plasma from
non-pregnant, normal pregnant, and preeclamptic women or measuring plasma markers
of endothelial dysfunction.
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a. Evidence for Endothelial Cell Dysfunction

i.) Histological and Cell Culture

Morphological observations of the vasculature highlight endothelial destruction
and dysfunction in preeclampsia. Glomerular endotheliosis is a common pathological
finding and direct evidence of endothelial cell involvement. In glomerular endotheliosis,
there is swelling of glomerular capillary endothelial cells, often blocking capillary
lumens, and deposition of protein between the basal lamina and endothelial cells

1.

Additional histological evidence of endothelial and vessel damage in preeclampsia is
"acute atherosis" in decidual vessels, which is similar to atherosclerotic foam cell
formation 58.
Initial in vitro experiments tested if preeclamptic serum was cytotoxic to human
umbilical vein endothelial cells (HUVECs) using radiolabeled chromium (5 1 Cr) release
60

.

Cells treated with preeclamptic serum showed increased levels of 5 1 Cr in the cell

supernatant, which illustrated that cell permeability was compromised

60

.

Cytotoxic

effects quickly disappeared with treatment of post-delivery serum, which parallels the
abatement of preeclamptic symptoms following delivery 60 . Further research, however,
clarified that preeclamptic serum was not cytotoxic, but rather, caused selective
activation of endothelial cells

61 .

Using phase contrast microscopy and fluorescence

activated cell sorting, it was determined that membrane integrity remained intact
following treatment with preeclamptic serum 6 1 . The conclusion that preeclarnptic serum
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was not cytotoxic to endothelial cells was confirmed by Endresen et al. using a broad set
of cytotoxicity measurements including

51

Cr release, Trypan blue exclusion, plating

2
efficiency, DNA and protein synthesis, and cell growth 6 .

ii.) PGl2 and TXA2

Prostaglandins and thromboxanes are 20-carbon unsaturated fatty acids derived
from AA upon cleavage of membrane phospholipids by phospholipase A2 (PLA2),
followed by COX activation (Figure 3). Although they are similar in structure, their
actions are varied and often opposing. All, however, are characterized by local
production, short half-lives, and inhibition by anti-inflammatory agents 63.
PGI2 is a prostaglandin produced from AA by COX and PGI2 synthase 64 . PGii is
a potent vasodilator and inhibitor of platelet aggregation. The production of PGI2 by
endothelial cells exceeds all other prostaglandins, suggesting a significant physiological
role 63. Thus, PGI2 production is an excellent gauge for endothelial cell homeostasis and a
deficiency in PGI2 could explain hypertension in preeclampsia. Accordingly, decreased
PGii levels are the best evidence for endothelial cell dysfunction in preeclampsia.
Measurement of the stable PGl 2 metabolite, 6-keto prostaglandin F l a (6-ketoPGF 1 .), in
plasma and urine has demonstrated decreased PGh biosynthesis in preeclamptic
compared to normotensive pregnant individuals. Recently, a comprehensive longitudinal
study by Chavarria et al. showed that plasma PGl2 was significantly decreased by the
4
third trimester in preeclamptic as compared to normally pregnant women 6 . This is

consistent with previous measurements

17• 65

.
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These data correlate with decreased urine

PGI2 levels in women with preeclampsia as compared to women with normal pregnancy.
An initial study showed a significant increase of urine PGi i levels during normal
pregnancy, but less of an increase in preeclamptic pregnancy

66
•

Mills et al. confirmed

that women with preeclampsia had significantly lower excretion of PGI2 metabolites
throughout pregnancy as compared to normal pregnant women, even prior to clinical
symptoms as early as 13 to 16 weeks ofgestation 67 .
Initial in vitro studies with preeclamptic plasma reported conflicting results
concerning endothelial PGI2 production. Preeclamptic plasma was reported to both
decrease 68• 69 and increase PGI2 production by HUVECs 10-12 . Baker et al. clarified that in
vitro PGh production by HUVEC was dependent upon the length ofplasma incubation.
Acute administration of preeclamptic plasma increased PGI2 (by stimulating COX), but
longer incubations with preeclamptic plasma decreased PGI2 concentrations (by
inhibiting PGI2 synthase) 73 • 74 . HUVECs treated with preeclamptic plasma, as compared
to those treated with normal pregnant plasma, also were shown to have increased
triglyceride incorporation and reduced PGI2 production 68. This study suggested a link
between hyperlipidernia and altered endothelial cell function in preeclampsia
TXA2 is an AA metabolite produced by COX and thromboxane synthase. It is a
potent vasoconstrictor. Chavarria et al. showed that plasma TXA2 was elevated as early
as 9 weeks of gestation in women destined to develop preeclampsia

46 .

In women that

developed severe preeclampsia, TXA2 was two times as high as those diagnosed with
mild preeclampsia. Similarly, Wang et al. showed significantly elevated plasma TXA2
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levels in women with severe preeclampsia in comparison to women with mild
preeclampsia 43 . Urine TXA2 metabolites were also elevated in women with preeclampsia
67 • 7 5 • 76
.

Elevation of urinary TXA2 metabolites was observed as early as 21 weeks

gestation 67 and 25 weeks gestation 76, indicating that altered TXA2 levels precede clinical
symptoms. Urinary excretion of TXA2 metabolites decreased rapidly to normotensive
levels by 24 hours post-partum 75 .
The TXA2/PGh imbalance strongly suggests endothelial cell dysfunction in
preeclampsia. Although many tissues produce PGI2 and TXA2, endothelial cells produce
the greatest quantity of PGI2, so decreased PGI2 production in preeclampsia indicates
impaired endothelial function.

iii.) Coagulation Abnormalities

The procoagulant state of preeclampsia, evidenced as disseminated intravascular
coagulation, microthromboses, and uteroplacental circulation restriction may reflect
endothelial cell activation. In vivo studies demonstrated decreased anticoagulant protein
levels (antithrombin III, protein C, and protein S) and increased procoagulant protein
expression. Elevated plasma levels of tissue factor, von Willebrand factor, platelet
activating factor (PAF), �-thromboglobulin, cellular fibronectin, and thrombomodulin
strongly suggested endothelial cell dysfunction in preeclampsia 77. Endothelial cells
release ET and von Willebrand factor following endothelial cell damage and/or
coagulation system activation. von Willebrand factor initiates platelet activation while

endothelin causes vasoconstriction of subjacent vascular smooth muscle

77 .
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ETs form a

family of vasoactive peptides with the primary ET, ET-1, released from endothelial cells
78 •

Clark et al. correlated ET elevation during preeclampsia with a rise in plasma uric acid

79 .

Elevated plasma uric acid levels, caused by a decrease in uric acid clearance, indicated

glomerular damage that reflected disease severity and altered glomerular filtration rate 79•
Fibronectin is a high-molecular-weight surface glycoprotein ofendothelial cells involved
in cell adhesion and migration. Fibronectin is constantly shed into the circulation but at
increased concentrations during endothelial cell damage, making it a good marker for
endothelial cell activation. Longitudinal studies showed significantly elevated plasma
levels of fibronectin by the second

80

and third trimesters

81

in preeclamptic women as

compared to normal pregriant women.

iv.) Cell Adhesion Molecules

Investigators also have measured plasma levels of soluble cell adhesion molecules
to determine endothelial cell dysfunction in preeclampsia

82-87 .

Intercellular adhesion

molecule- I (ICAM- I ) and vascular cell adhesion molecule- I (VCAM- I ) are
constituently expressed on endothelial cells. These proteins are shed into the circulation
upon endothelial cell damage or dysfunction. In preeclamptic plasma, Austgulen et al.
found elevated concentrations of soluble ICAM- I, VCAM- 1, and E-selectin 84. This was
corroborated by Krauss et al. who reported elevation of both ICAM- I and VCAM- I

88.

They concluded that elevated second trimester VCAM-1 and ICAM- I levels were
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predicative of developing preeclarnpsia . Other investigators have observed increased
soluble VCAM-1, but not ICAM-1 levels 85 • 89 ' 90 . Finally, a study conducted at 18 weeks
of gestation found an increase in ICAM-1, but not VCAM-1, in women destined to
develop preeclampsia 83 . The levels did not correlate with endothelial cell dysfunction
and instead were suggested to reflect abnormal placentation, which occurs prior to 20
weeks of pregnancy. The reason for discrepancies between some studies is not known,
but overall, it appears that VCAM-1, and probably ICAM-1, levels are elevated in
women with preeclarnpsia, which is consistent with endothelial cell dysfunction. The
levels, however, apparently vary throughout pregnancy and may reflect
pathophysiological processes occurring prior to endothelial dysfunction and the clinical
manifestation ofpreeclarnpsia.

b. Explanations for Endothelial Cell Dysfunction

i.) Hyperlipidemia and Dyslipidemia

Dyslipidemia could mediate endothelial cell dysfunction in preeclampsia. It is
well documented that both hyperlipidemia and lipid profile alter the expression of
adhesion molecules and the general function of the endothelium

9 1 95 .
-

Potter et al.

demonstrated increases of cholesterol and triglyceride during pregnancy, which peaked in
the second and third trimesters, and declined sharply with delivery

96

.

Thus, normal

pregnancy is characterized by hyperlipidemia. In preeclarnpsia, however, triglycerides are

significantly elevated above normal pregnant levels

96• 97

.
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This difference was present at

ten weeks of gestation in women destined to develop mild and severe preeclampsia, and
was not observed in pregnant women with other forms ofhypertension 97 .
In conjunction with hyperlipidemia, there is evidence that preeclarnptic women
have altered lipid profiles. Serum FFAs were increased in preeclamptic patients, and
44

positively correlated with serum triglycerides and MDA

.

Elevated FFAs included:

palmitic (16:0), oleic ( 1 8: 1 n-9), and linoleic (18:2 n-6) acids 98 • 99 . These alterations were
present as early as 17 weeks of pregnancy in women destined to become preeclamptic,
and were also present in women with preeclarnpsia

98 .

There was no difference in the

level or the composition of esterified fatty acids in early pregnancy between normal
pregnant and preeclamptic groups

98

.

In later pregnancy, however, women with

preeclarnpsia had increased oleic acid in the phospholipids fraction, and had decreased
linoleic acid in the phospholipid and triglyceride factions

98 .

These data confirm earlier

work that characterized the preeclamptic state by decreased esterified PUFAs, including
linoleic acid, linolenic acid, and eicosapentaenoic acid

100 .

Decreased PUFAs, later once

preeclampsia is established, may indicate maternal oxidative stress, since PUFAs are
vulnerable to oxidation.
Further studies demonstrated that fatty acid composition, particularly levels of
certain PUFAs, may influence one's risk of developing preeclampsia. Williams et al.
showed that women with the lowest levels of omega-3 PUFAs (n-3), a PUFA rich in fish
oil, had a 7.6-increased risk of developing preeclampsia

101

.

A later study confirmed this,

showing that women with increasing levels of n-3 PUFAs had decreased risk for
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developing preeclampsia 10 . In contrast, their risk was increased with higher levels of n-6
2

2
PUFAs, especially for AA 10 . This was corroborated by studies that have demonstrated
elevated AA in maternal serum phospholipids and cholesterol esters 103 and increased
total plasma AA concentrations

104

in preeclamptic as compared to normal pregnant

women.
These data would suggest that dietary modifications might be beneficial in
preventing preeclampsia Research substantiates this proposal demonstrating that diets of
women who develop preeclampsia were characterized by increased consumption of total
lipids, particularly of palmitic, stearic, oleic and linoleic acids 105. A prospective study
also showed that a greater intake of PUF As lead to an increased risk of developing
preeclampsia

1 06

.

Since linoleic acid is a precursor to AA and its inflammatory

metabolites, dietary restrictions of linoleic acid might be helpful in preventing the
development of preeclampsia. In preeclampsia, accumulation of linoleic acid and AA by
endothelial cells could alter eicosanoid synthesis

69

and contribute to the TXAi/PGI2

imbalance. In contrast, ingestion of omega-3 PUFAs would alter AA metabolism, leading
to the production of thromboxane A3 , a much less potent vasoconstrictor than TXA2, and
production of PGI 3 , a vasodilator as potent as PGI2, to maintain TXA2/PGI2 levels that
favor vasodilatation.
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ii.) Neutrophils

One theory of endothelial cell dysfunction proposes that neutrophils are activated
as they circulate through the intervillous space by lipid peroxides secreted by the placenta
(Figure 5). As they return from the intervillous space to the maternal circulation, they
produce systemic vascular cell damage by adhering to endothelial cells

14 • 1 07

.

Thus,

neutrophils would transfer the oxidative stress of the placenta to the maternal
compartment. Neutrophil activation causes enhanced expression of cell adhesion
molecules and release of proteolytic enzymes, ROS and cytokines, which can directly
damage the endothelium. Endothelial cell adhesion molecules mediate leukocyte binding
in preparation for neutrophil transendothelial migration. Greer et al. first demonstrated
neutrophil activation in preeclampsia by showing elevated plasma levels of neutrophil
elastase

108 .

Plasma levels of neutrophil elastase were correlated with plasma levels of

von Willebrand factor, suggesting that neutrophil activation could be responsible for
endothelial cell dysfunction

108 .

iii.) ROS

The vasculature, specifically the endothelium, is both a target for and a source of
many oxidant species. Oxidants, such as ONOO-, lipid peroxides, oxidized LDLs, and
02·-, directly damage endothelial cells. All of these species can act as toxic agents and
could propagate placental oxidative stress to the maternal compartment.
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The presence of ROS in the maternal circulation could affect endothelial
vasoactive pathways resulting in endothelial cell dysfunction. An example is impairment
of NO' signaling, which is evidenced by inhibition of endothelium-dependent relaxation
in coronary ring preparations in the presence ofOi-

109
.

The role ofNO' in preeclampsia

has yielded conflicting results. Studies have demonstrated unchanged, reduced or
elevated circulating NO' metabolites in preeclampsia compared to normal pregnancy

1 09.

During preeclampsia NO' production may be reduced locally in endothelial cells due to
the interaction of NO' and abundant 02 ·-. Not only does this reaction produce the
powerful ONOO-, which acts as an oxidant, it also decreases the NO' available to mediate
vasorelaxation. Therefore, increased 02 ·- in preeclampsia may not directly cause
vasoconstriction, but it may prevent NO' from completing its vasorelaxant role. This
speculation was supported by immunohistochemical staining of increased ONOO- and
endothelial nitric oxide synthase (NOS) staining and decreased SOD in endothelial cells
of preeclamptic women as compared to normal pregnant women

1 1 0.

Additionally,

Davidge et al. has demonstrated decreased NO' production from HUVECs upon
treatment with preeclamptic plasma. Isolation and purification studies suggested that
oxidized LDL was the mediating factor. They speculated that perhaps NO' is increased in
preeclampsia, but in the presence ofoxidative stress it is rapidly converted to ONOO- so
that local endothelial cell NO' levels are decreased

111.

Finally, ONOO- is not only a

result of oxidative stress, but also a strong oxidant that may directly attack endothelial
cell membranes to cause cell necrosis or apoptosis, resulting in increased cell
permeability and fluid loss 109•
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Treatment of HUVECs with preeclamptic plasma (containing elevated lipid
peroxides, as measured by MDA) activated NF-KB and up-regulated ICAM- 1 expression,
which was inhibited by vitamin E 1 12. These data suggested that lipid peroxides in the
plasma were the mediators ofendothelial cell activation. NF-KB activates the interleuk:in8 (IL-8) promoter to increase IL-8 expression. Simultaneous expression of ICAM- 1 and
IL-8, a potent neutrophil chemokine, suggests a mechanism for neutrophil
transendothelial migration.
ROS, generated by activated neutrophils, also could damage endothelial cells to
cause dysfunction. For example, Oi "- attacks AA in cell membranes to produce
vasoconstrictive isoprostanes, which also could propagate lipid peroxidation within the
maternal vasculature.

iv.) Cytokines

Cytokine production by the placenta or leukocytes also could activate endothelial
cells as part of the pathophysiological process of preeclampsia. Cytokine levels correlated
with VCAM-1 expression in the maternal circulation suggesting interaction between
activated leukocytes and endothelium

1 1 3.

Cytokines, such as TNFa, IL- l f3, and IL-2,

affect endothelial cell prostaglandin formation and may enhance the PGh and TXA2
imbalance.
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v.) STEM deportation

STEM deportation into the maternal circulation, which is increased in
preeclamptic patients, also has been suggested to be the toxic agent responsible for
endothelial cell dysfunction 1 1 4. In vitro research showed that incubation of STEM and
HUVECs suppressed cell proliferation and altered cell integrity

1 1 5.

Cockrell et al.

confirmed STEM-induced endothelial dysfunction by demonstrating that perfusion of
subcutaneous arteries with STEM vesicles inhibited endothelium-dependent vasodilation
1 16•

Finally, ultrastructural endothelial cell disruption of STEM-perfused arteries was

validated using transmission electron microscopy.

These studies suggest that oxidative stress is spread within the maternal
compartment by placental-derived toxic agents, which produce direct damage of the
endothelium while interacting with maternal vascular constituents to generate additional
oxidants and to promote further destruction. The condition of the maternal circulatory
system prior to pregnancy (e.g., diabetes, hyperlipidemia, obesity, etc.) could exacerbate
the propagation of oxidative stress during pregnancy. In preeclamptic pregnancy,
maternal oxidative damage leads to a dysfunctional endothelium, unable to regulate
smooth muscle tone, resulting in hypertension.
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iii. Neutrophils

The primary role of neutrophils or polymorphonuclear leukocytes is the killing
1 1 7.

and phagocytosis of pathogens for host defense

Neutrophils release destructive

agents, such as ROS and proteolytic enzymes, to fulfill this function

1 17

.

Cytok:ines,

including TNFa and IL-6, modulate or "prime" rieutrophils for enhanced activation, but
do not themselves activate neutrophils

1 1 8• 1 1 9
.

Neutrophils have plasma membrane

receptors that interact with specific chemoattractants to initiate activation events,
including: chemotaxis, respiratory burst, phagocytosis, degranulation, and
transendothelial migration

1 1 9•

These end results are mediated by various cell signaling

pathways, which are activated by certain stimuli

1 19.

Recently, neutrophils have been

implicated in many diseases because unchecked neutrophil activity causes damaging
tissue degradation and can lead to inflammatory conditions 1 20 .
A great deal of evidence suggests that uncontrolled neutrophil activation may play
a significant role in the pathophysiology of preeclampsia. Neutrophils are likely
mediators in preeclampsia for several reasons: 1) they are the most abundant of the
leukocytes, 2) their numbers increase in pregnancy
preeclampsia

121 ,

1

,

3) their numbers further increase in

and 4) they produce toxic substances (ROS, myeloperoxidase (MPO),

TXA2, and TNFa), which could cause endothelial and vascular smooth muscle cell
dysfunction and lead to vasoconstriction and proteinuria.

a Evidence for Neutrophil Dysfunction
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i.) Neutrophil Elastase

Greer et al. first demonstrated neutrophil activation in preeclampsia by measuring
significantly elevated plasma levels of the neutrophil protease, elastase, in preeclamptic
patients

1 22 .

Elastase is a potent enzyme released as a host-defense mechanism upon

neutrophil activation

1 23 .

It is stored pre-packaged in the azurophil granules and is

released to degrade bacteria and connective tissue during inflammation 1 23 . The presence
of neutrophil specific elastase in plasma indicated in vivo lysosomal granule release and
thus, neutrophil activation. It also suggested a potential mechanism for endothelial cell
dysfunction in preeclampsia mediated by neutrophil release of ROS, cytokines, and
proteases. Further investigation compared maternal and umbilical vein plasma neutrophil
elastase levels and found neutrophil activation was confined to the maternal compartment
1 24 .

Immunocytochemical evidence of increased elastase production and neutrophil

infiltration in the decidua, but not in the placenta or subchorionic plate, suggested that the
mechanism of neutrophil activation may occur at the maternal-fetal interface

1 25 .

Recently, plasma levels of the proteolytic MPO enzyme, also released by activated
neutrophils, were found to be elevated during preeclampsia 126 .
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ii.) Neutrophil ROS

The respiratory burst is the primary result of neutrophil activation. It is also a
useful tool to measure neutrophil activity. Tsukimori et al. measured neutrophil 02·
production using a SOD-inhibited reduction of ferricytochrome C with a
spectrophotometer to first demonstrate that neutrophils from preeclamptic patients had
greater spontaneous 02·- production than those from normal pregnant and non-pregnant
patients

127 .

Furthermore, neutrophils, primed with N-formyl-methionyl-leucyl

phenylalanine residues (fMLP), and incubated with sera from preeclamptic patients had
twice the neutrophil 02·- production than sera from normal pregnant patients. There was
no significant difference between non-pregnant and normal pregnant groups. Since
preeclamptic serum enhanced neutrophil 02·- release, it was suggested that a humoral
factor activates neutrophils.
Sacks et al. used whole blood flow cytometry to show that basal intracellular ROS
values of granulocytes, monocytes, and lymphocytes were significantly greater for
preeclamptic as compared to normal pregnant and non-pregnant women

1 28 .

The

oxidative burst showed an increasing trend from non-pregnant, to normal pregnant, to
preeclamptic patients. Thus, the evidence clearly supports that neutrophil intracellular
ROS and respiratory burst are altered in preeclampsia.
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iii.) Neutrophil Adhesion Molecules

Measurements of neutrophil adhesion molecules further confirm neutrophil
activation in preeclampsia Expression of the neutrophil integrins, CD l l b and CD64,
were increased in both normal pregnant and preeclamptic patients

128

.

In addition, there

was a decrease in L-selectin expression on neutrophils from preeclamptic women

128

.

Quantitative flow cytometry confirmed that there was increased CD 1 1b and decreased L
selectin expression on neutrophils from preeclamptic patients 82• 129• 130. Furthermore, the
enhanced CD 1 1b expression positively correlated with plasma uric acid levels in women
with preeclampsia, suggesting that neutrophil activation reflected disease severity 82 . An
animal study also demonstrated neutrophil activation by measuring adhesion molecules in
an experimental rat model of preeclampsia induced by low-dose endotoxin

13 1 .

While

neutrophils from healthy pregnant rats exhibited an up-regulation of CD1 l a and CD49d,
there was even greater CD 11 b and CD49d expression and a decrease of L-selectin on
neutrophils from the endotoxin-induced preeclamptic rats

131 .

One study, however, did

not find an alteration in the expression of cell adhesion molecules (CDl I , CD18, and
2
CD26) on neutrophils isolated from non-pregnant, pregnant, and preeclamptic women 13 .

iv.) Neutrophil Lactoferrin

Neutrophil lactoferrin release and locomotion have also been analyzed. Crocker et
al. observed no significant difference in lactoferrin production among neutrophils

obtained from non-pregnant, pregnant, and preeclamptic women
or serum also did not alter neutrophil locomotion

1 33 .
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Preeclamptic plasma

132.

These data suggested that specific

rather than general neutrophil activation occurs in preeclampsia.

b. Causes for Neutrophil Dysfunction

These studies support the idea that a certain stimulus, most likely a plasma
component, activates specific neutrophil pathways in preeclampsia. Research groups
have investigated a variety of potential neutrophil activators including: fatty acids,
cytokines, complement molecules, and STBM particles

1 3 4-138

.

One hypothesized

mechanism of neutrophil activation proposes that neutrophils become "activated" from
placental-derived lipid peroxides and TNFa in the intervillous space (Figure 5)

107.

i.) Lipids

The altered lipid profile of preeclampsia may lead to neutrophil activation in both
the intervillous space and the maternal circulation. Major fatty acid concentrations are
normally modified in the pregnant state and further altered in preeclampsia Specifically,
both palmitic and Iinoleic acids are elevated in women with preeclampsia 98. Crocker et
al. demonstrated that PUFA incorporation lead to altered neutrophil NADPH oxidase
function, producing enhanced respiratory bursts

1 34

.

PUFAs also may directly alter

NADPH oxidase activation. Gorog et al. showed direct and differential activation of the

respiratory 02·- burst by oxidized PUFAs

1 9
3 .
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This mechanism could account for

excessive 02._ production in preeclampsia, since elevated plasma FFAs and free radicals
would produce oxidized PUFAs.

ii.) Cytokines

Cytokines, from various sources, may be involved in neutrophil activation during
preeclampsia. TNFa, TNFa receptor, interleukin-6 (IL-6), and interleukin-12 (IL-12) are
all increased in preeclamptic plasma 13> 137, The placenta, activated endothelial cells, or
activated neutrophils could secrete these cytokines, and by exerting paracrine or autocrine
effects, induce genomic changes to alter cell function. TNFa and IL-6 are known to
prime neutrophils, which enhances subsequent activation, perhaps by a preeclampsia
specific agent, such as lipid peroxides 1 1 s. 1 19•

iii.) Complement

Neutrophil activation in preeclampsia also could occur by the complement
system. The terminal complement complex, C5a, is increased in the severe preeclamptic
state and could activate neutrophils

1 4 0.

Furthermore, C5a and neutrophil elastase levels

positively correlated in plasma from preeclamptic patients, while in vitro work showed a
dose-dependent release of neutrophil elastase upon stimulation with recombinant C5a

1 40 .

Another study, however, did not find evidence that the complement system was activated

in mild preeclampsia

126

•
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These investigators reported that C4b and levels of other

complement mediators in preeclamptic women were comparable to those ofnon-pregnant
women.

iv.) SIBM particles

More SIBM particles are shed from the placenta in preeclampsia than normal
pregnancy

1 14

.

These particles could potentially link placental and endothelial cell

dysfunction in preeclampsia. Endothelial cell activation by SIBM also could lead to the
release of factors that activate neutrophils

1 1 5• 1 4 1

.

The involvement of SIBM particles in

neutrophil activation was analyzed by changes of intracellular calcium, pH, and ROS in
the presence of supematants from cultured HUVECs previously exposed to SIBM

1 38.

The supernatants increased neutrophil intracellular calcium and ROS concentrations, and
decreased intracellular pH, demonstrating a mechanism for neutrophil activation in
preeclampsia 1 3 8.

The mechanism for neutrophil activation during preeclampsia is not clear. There
is, however, a growing understanding of the complex inter-relationship among lipids,
cytokines, complement, STBM particles, and neutrophil activation. Since the exact
relationship ofneutrophil activation and endothelial cell dysfunction remains elusive, it
must be determined ifneutrophils are the primary stimulus for endothelial activation or if
they are activated secondarily to endothelial cell damage. In Chapter 5, we present
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evidence for the former by demonstrating massive neutrophil adherence to endothelial
cells and infiltration into systemic vasculature in women with preeclampsia

iv. Vascular Smooth Muscle, Endothelial, and Neutrophil Interaction

The preceding review demonstrates that the vasculature is a dynamic
environment. Vascular smooth muscle cells, endothelial cells, and neutrophils interact
and respond to various physiological and pathophysiological conditions to maintain
homeostasis. Coordinated and appropriate behavior is achieved through cellular
communication by mediators, such as cell surface receptors, adhesion molecules,
cytokines, chemokines, and ROS. Interaction among dysfunctional vascular smooth
muscle cells, endothelial cells, and neutrophils in preeclampsia may lead to uncontrolled
neutrophil transendothelial migration, which could explain the clinical symptoms of
preeclampsia.
Transendothelial migration or diapedesis is a multi-step process coordinated by
expression of chemotactic agents and various adhesion proteins on neutrophils and
endothelial cells (Figure 6). The mechanism of neutrophil transendothelial migration
consists ofmargination (rolling and capture), firm adhesion, and extravasation. Each step
is controlled to direct specific aspects of neutrophil transendothelial migration 1 42 .
Margination occurs under normal physiological circumstances. Neutrophils roll
along the vessel wall and transiently adhere to the endothelium via constitutively
expressed leukocyte selectin (L-selectin). Selectins are transmembrane glycoprotein
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adhesive molecules that consist of a calcium-dependent lectin domain on the extracellular
NHi-terminus that is j oined to an epidermal growth factor-like domain. Short consensus
sequences bind extracellular domains to a short intracellular domain, which is coupled to
signaling molecules. The L-selectin ligand is CD34, a long protein chain molecule with
0-linked sugar and sialyl groups 1 43 .
Inflammatory stimuli such as complement, ROS, and certain cytokines increase
platelet selectins (P-selectin) and endothelial selectins (E-selectin) of endothelium to
facilitate irreversible neutrophil binding. P-selectin is stored in intracellular Weibel
Palade bodies of endothelial cells. Appropriate inflammatory stimuli induce mobilization
of P-selectin to the cell surface. P-selectin interacts with P-selectin glycoprotein ligand- I
(PSG- 1), which is constitutively expressed on neutrophils, to slow rolling and establish
firm neutrophil-endothelial attachments. PSG-1 is a protein ligand molecule, similar to
CD34, modified by 0-linked sugar and sialyl groups. It is a homodimer, however, and
can simultaneously bind two P-selectin ligands. E-selectin expression, unlike P-selectin,
requires gene transcription and translation following endothelial cell stimulation. The
time necessary for E-selectin mobilization may coordinate with the down-regulation of P
selectin to maintain neutrophil rolling and adhesion. In vivo and in vitro evidence
demonstrate that E-selectin binds protein ligands, similar to those for P- and L-selectin,
with sugar and sialyl group modifications

14 3

.

Complementary surface receptors on neutrophils (L-selectin) and endothelium (P
and E-selectins) mediate neutrophil rolling and capture. Neutrophils begin to adhere
firmly to the endothelium upon integrin and cell adhesion molecule expression. Integrin
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up-regulation occurs in a timely, sequential manner by inflammatory cytokines or by
signaling ofactivated selectins. Since L-selectin has cytoplasmic domains linked to signal
transduction machinery, it is a likely candidate for the activation of neutrophil integrins
1 43

Integrins are a group of heterodimeric transmembrane glycoproteins involved in
neutrophil cell-cell and cell-extracellular matrix adhesion. Each integrin contains an
extracellular a- and 13-subunit for ligand binding and a cytoplasmic domain with
phosphorylation sites and signal transduction proteins. Macrophage antigen- I (Mac-1;
aMf32; CD 1 l b/CD 18) is an important neutrophil integrin in transendothelial migration.
Neutrophils package Mac-1 in secretory vesicles and granules for rapid mobilization.
Potent Mac-1 stimulators, including the bacterial fMLP peptide, cause degranulation.
Lipopolysaccharide (LPS) and TNF-a, as weaker stimuli, mobilize Mac-1 secretory
vesicles for cell surface expression 1 43 .
ICAM-1 on endothelial cells interacts with the neutrophil Mac- 1 integrin to
mediate firm binding. ICAM-1 is an irnrnunoglobulin-like molecule that is constitutively
expressed on endothelium. It is greatly up-regulated in the presence of inflammatory
cytokines or oxidative stress

1 44

•

VCAM-1 is similar to ICAM-1, but functions in the

transmigration of monocytes and eosinophils by binding to 13-1 integrins. Neutrophil
transendothelial migration may use both ICAM- 1 and VCAM- 1

143

.

Following tight adhesion of neutrophils to the endothelium, neutrophils migrate
through intercellular junctions and move toward a chemotactic stimulus within the
interstitial tissue

142

.

The exact extravasation mechanism, unlike the previously described
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steps of transendothelial migration, is not clear. It is understood, however, that plateletendothelial cell adhesion molecule (PECAM- 1) of endothelium is an important homing
receptor, strategically positioned at intercellular junctions where neutrophil
transendothelial migration occurs. PECAM- 1 has an immunoglobulin domain that can
form homodimers with PECAMs on other cells, such as neutrophils 1 43 .
Soluble exogenous or endogenous mediators regulate the process of vascular cell
activation and neutrophil transendothelial migration. These mediators can be further
classified as non-chemoattractant or chemoattractant. Non-chemoattractant cytokines,
such as TNF-a and IL- 1 , increase expression of adhesive proteins, but are not
chemoattractant for neutrophils. These inflammatory cytokines up-regulate adhesion
molecules on neutrophils and endothelial cells in preparation of transendothelial
migration. Directed transendothelial migration, however, requires neutrophil
chemoattractants. Chemokines are chemotactic cytokines that mediate inflammation

1 45 .

They form a group of approximately forty proteins that share a common four cysteine
residue structure, which is used to classify chemokines and produces varying leukocyte
chemoattractant responses 1 43.
Neutrophils have receptors for chemoattractant agents: IL-8, platelet activating
factor (PAF), C5a complement protein, leukotriene B4 (LTB4), and tMLP. A variety of
cells produce these neutrophil chemoattractants. fMLP is an exogenous mediator, while
LTB4 and PAF are important endogenous mediators. Monocytes and neutrophils produce
LTB4 from AA. LTB 4 is 10 to 1000 times more potent than PAF in causing neutrophil
chemotaxis 1 43 .
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The chemokine, IL-8, is a primary stimulus for neutrophil transendothelial

migration during inflammation. IL-8 is a C-X-C or a-chemokine

4
1 2.

The C-X-C reflects

separation of conserved cysteine residues by an amino acid. Neutrophils contain two C
X-C receptors (CXCRI & CXCR2), which both couple to IL-8. Other C-X-C
chemokines, however, only bind CXCR2

1 43 .

This may explain the potent and specific

neutrophil chemoattraction to IL-8. Leukocytes, endothelial cells, and smooth muscle
cells produce IL-8 under conditions of oxidative stress and upon stimulation with IL-I or
TNFCl

1 42

Investigators only recently began to look for neutrophil transendothelial migration
into systemic tissues during preeclampsia. Initially, immunohistochemical staining of
elastase and neutrophils demonstrated the presence of neutrophils in the decidua and
spiral arteries of preeclamptic patients

125.

In systemic maternal tissue, Reister et al.

illustrated neutrophil infiltration and described elevated IL-8 concentrations in the
characteristic glomerulonephritis lesion of preeclampsia

1 46 .

There was also histological

evidence of neutrophil infiltration into liver tissue of women with hemolysis, elevated
liver enzymes, and low platelets (HELLP) syndrome and eclampsia

1 47 .

Finally, an

animal model of endotoxin-induced preeclampsia had evidence of neutrophil
.
.
.
.
.
transendothehal migration, showmg infiltratJon ofthe 1·1ver and kidneys

1 3 1 , 1 48, 1 49.

E. Summary
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Preeclampsia is a multi-system disorder characterized by maternal vascular cell
dysfunction. It is thought that oxidative stress, originating in the placental compartment,
produces the various pathophysiological features ofpreeclampsia. Specifically, placental
ischemia-reperfusion generates localized oxidative stress, which is then propagated
within the placenta. As the placenta grows, maternal oxidative stress gradually increases
as more placental-derived oxidant agents, including lipid peroxides, ROS, activated
neutrophils, cytokines and SIBM particles, enter the maternal circulation, linking the
primary placental pathology to the maternal compartment. These oxidant agents interact
with vascular smooth muscle cells, endothelial cells and neutrophils to overwhelm
maternal antioxidant mechanisms and exacerbate oxidative stress. It is a vicious, self
propagating cycle of cell-cell and oxidant-cell activation that culminates in the clinical
symptoms of preeclampsia. This complex interplay of placental-derived oxidant agents,
maternal vascular cells, and pre-existing maternal circulatory health determines the
clinical manifestation and progression ofpreeclampsia. Only when the primary stimulus,
the placenta, is removed will the pathological process ofpreeclampsia cease.

F. Purpose of Investigation

This investigation examined one of the possibilities for vascular cell dysfunction
in preeclampsia: Activation and transendothelial migration of neutrophils into systemic
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vascular tissue. We used in vitro studies to explore mechanisms related to oxidative stress
and hyperlipidemia that would create an environment conducive for transendothelial
migration of neutrophils. We used subcutaneous fat biopsy samples to determine if
transendothelial migration ofneutrophils actually occurs in women with preeclampsia
We first developed a methodology for isolating and culturing human vascular
smooth muscle cells for in vitro studies (Chapter 2). Second, we used these cells to
investigate whether oxidative stress in the presence oflinoleic acid stimulates vascular
smooth muscle cell production of IL-8 in culture (Chapter 3). We used linoleic acid
because it is elevated in the diet and plasma ofwomen with preeclampsia, and because it
is the precursor for AA and its metabolites that mediate inflammation. Third, we
evaluated the ability of oxidative stress in the presence of linoleic acid to activate
neutrophils by measuring superoxide production in real-time (Chapter 4 ). Last, we used
fat biopsy samples to examine whether there is vascular smooth muscle expression ofIL8, endothelial expression of ICAM-1, and neutrophil infiltration into systemic vascular
tissue in women with preeclampsia (Chapter 5).
These studies could provide evidence that dysfunction ofvascular smooth muscle,
endothelium and neutrophils are all linked to the pathogenesis of preeclampsia by
neutrophil transendothelial migration into systemic vascular tissue in response to vascular
smooth muscle production ofIL-8.

G. Hypotheses

1)
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Treatment of vascular smooth muscle cells with an oxidizing solution
enriched with linoleic acid will lead to increased production of IL-8, a
potent neutrophil chemokine.

2)

Treatment of neutrophils with an oxidizing solution enriched with linoleic
acid will stimulate neutrophils to produce superoxide.

3)

In the systemic vascular tissue ofwomen with preeclampsia, there will be:
a) increased expression of IL-8 by vascular smooth muscle, b) increased
expression of ICAM-1 by endothelial cells, and c) infiltration of
neutrophils.

H. Significance of this Research

If our overall hypothesis is correct that neutrophils infiltrate into systemic
vascular tissue in women with preeclampsia, this could explain vascular cell dysfunction
and the clinical symptoms of preeclampsia. Such findings would suggest the use of
antioxidants to reduce oxidative stress and dietary modifications, such as restriction of
linoleic acid, to decrease neutrophil activation and vascular IL-8 production. These
modifications could reduce vascular inflammation and inhibit neutrophil transendothelial
migration to prevent preeclampsia. Furthermore, these studies would suggest a role for
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neutralizing antibodies directed at IL-8 or cell adhesion molecules as novel treatments for
preeclampsia

Table 1 .

Reactive oxygen species and reactive nitrogen species.
Name

Symbol

Alkoxyl radical

Lo·

Hydrogen atom

f

Hydrogen peroxide

H202

Hydroxyl radical

HO"

Lipid peroxide

LOOH

Lipid radical

L"

Nitric oxide

NO'

Peroxynitrite anion

ONOO

Peroxyl radical

LOO'
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Comments: Formation/Examples
Formed by interaction ofsuperoxide and a lipid
peroxide; c�pable ofinitiating lipid peroxidation
f
02· + LOOH = LO' + Of + 02
The simplest free radical

f

Formed by the dismutation of superoxide

-

Protein radical
-

Superoxide

02·

Transition metals

Fe, Cu

Formed by metal-catalyzed decomposition of
hydrogen peroxide; highly reactive; attacks all
biological molecules
Formed by a peroxyl radical removing a hydrogen
from an adjacent lipid
LOO' + LH = LOOH + L.
Formed by the rem9val ofa hydrogen (common
f
agents: ONOO , Of , LOO"), occurring
preferentially at carbon-carbon double bonds of
unsaturated f�tty acids
LH + 02 ° = L·
Formed in vivo by conversion ofL-arginine into
L-citrulline by nitric oxide synthase (NOS)
Formed by interaction ofnitric oxide and
suoeroxide; capable ofinitiating lipid oeroxidation
Formed by the interaction ofa lipid radical and
molecular oxygen during lipid peroxide
propagation or by the transition metal-catalyzed
decomposition of lipid peroxide
L· + o2 = Loo·
Formed by removal ofa hydrogen from a protein
Formed by enzymatic or non-enzymatic one
electron reduction ofoxygen
02 + e = 02·Powerful catalysts of free radical reactions
because they can change their oxidation numbers

Table 2.
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Antioxidant enzymes and their actions.

Antioxidant Enzyme

Action

Superoxide Dismutase Reduces superoxide radical to hydrogen peroxide and
(SOD)
molecular oxygen
+

20/- + 2H
Catalase

H202 + 02

Converts hydrogen peroxide to molecular oxygen and
water
2H202

Glutathione
peroxidase

SOD

Catalase

02 + 2H20

Uses glutathione (GSH) as a hydrogen donor to convert
glutathione into glutathione disulfide (GSSG) to convert
hydrogen peroxide to water and lipid peroxide to water and
a fatty acid alcohol
2GSH + H202

glutathione peroxidase

GSSG + 2H20

GSSG + LOH + H20
2GSH + LOOH
glutathione peroxidase
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Figure 1.

Cellular enzymatic antioxidant mechanisms.

The body has three primary enzymes to neutralize ROS, g�nerated during oxidative
metabolism, so to prevent cell injury. SOD dismutates 02° to H202, which is then
metabolized by catalase or glutathione peroxidase to H20. (This figure was adapted from
Cellular Pathology I: Cell Inj ury and Cell Death. In: Cotran RS, Kumar V, Collins T, eds.
Robbins Pathologic Basis of Disease. Philadelphia: WB Saunders Company, 1999, p. 13.)
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Figure 2.

Free radical mechanism oflipid peroxidation.

Initiation of lipid peroxidation occurs when a free radical attacks a hydrogen atom of an
unsaturated fatty acid to form a lipid radical. Propagation oflipid peroxidation occurs
when that lipid radical reacts with 02 to form a highly unstable lipid peroxyl radical,
which attacks a nearby unsaturated fatty acid to form a lipid hydroperoxide and a new
lipid radical, so that the cycle is repeated. Propagation oflipid peroxidation also occurs in
the presence of transition metals. Definitions: XH = new unsaturated lipid; Me = metal,
with varying valence electrons; LOH = lipid alcohol; all other definitions, see Table 1.
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Lipid peroxides affect AA metabolism by stimulating COX and by inhibiting
prostacyclin synthase leading to an increase of thromboxane metabolites and a decrease
ofprostacyclin metabolites, respectively. ROS react with AA to produce isoprostanes,
which cause vasoconstriction.
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Hypothesized cascade in the development of clinical symptoms of
preeclampsia.

Pregnancy is characterized by a gradual increase in oxidative stress due to secreted lipid
peroxides by the placenta and activated leukocytes. In normal pregnancy, there is a
parallel increase in antioxidants. In preeclampsia, there are increased levels oflipid
peroxides, in addition to lower levels ofantioxidants. These patients also tend to have
pre-existing oxidative stress. Clinical symptoms of preeclampsia occur when oxidative
stress overwhelms the maternal compartment. (Adapted from Walsh, S.W. Maternal
Placental Interactions ofOxidative Stress and Antioxidants in Preeclampsia. Seminars in
Reproductive Endocrinology, 1 998; 16:93-104.)
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Theory o f neutrophil activation i n the intervillous space i n preeclampsia.

Neutrophils are activated as they circulate through the intervil lous space by lipid
peroxides secreted by the placenta. Neutrophils return to the maternal compartment to
produce vascular damage by producing superoxide and by adhering to endothelial cells.
(Used with permission of artist. From Walsh, S.W. The role of oxidative stress and
antioxidants in preeclampsia. Contemporary OB/GYN, 1 997; 42: 1 1 3- 1 24.)
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The multi-step process of neutrophil transendothelial migration.

Neutrophil s transiently bind to selectins on endothelium, to create a rolling motion, as
they circulate through the vasculature. Firm adhesion of neutrophils to endothelial cells
occurs with increased expression of ICAM- 1 and integrins upon stimulation with
inflammatory mediators. A chemotactic signal causes neutrophils to flatten onto the
endothelium and extravasate into systemic tissue.

Chapter 2

SIMPLE AND ECONOMICAL METHOD FOR ISOLATION AND
CULTURE OF ARTERIAL SMOOTH MUSCLE CELLS
FROM CHORIONIC PLATE ARTERIES

A. Introduction

Vascular smooth muscle cells regulate the diameter of blood vessels by
modulating their contraction in response to neural, hormonal and chemical signals. Thus,
vascular smooth muscle plays an important role in maintaining cardiovascular function.
Hemodynamic regulation is especially critical during pregnancy when cardiac output
increases while total peripheral resistance decreases. In preeclampsia, vascular smooth
muscle function may be altered to cause hypertension.
To explore mechanisms for vascular smooth muscle dysfunction in preeclampsia,
we considered studies with primary cultures of vascular smooth muscle. Primary cultures
of adult vascular smooth muscle cells, however, can be difficult to obtain and
commercially available cells are expensive. The age of the donor is often advanced and
health problems ofthe donor may have altered the phenotype ofthe cells. There is always
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a question as to whether donor cells are truly normal. A readily available source of
normal vascular smooth muscle cells would be useful.
The purpose of this study was to develop a simple and economical method to
obtain normal vascular smooth muscle cells for in vitro studies. This has been done for
endothelial cells, which are commonly used for cardiovascular studies, by isolating
endothelial cells from human umbilical veins. We applied a similar rationale and
developed a simple and economical technique, based on the work of Graham et al. for
establishing primary cultures of intestinal smooth muscle cells

1 50,

to isolate and culture

arterial smooth muscle cells from placental chorionic plate arteries.

B. Materials and Methods

1. Placental Arterial Smooth Muscle (PASM) Cell Isolation and Culture

Placentas were collected at the time of term delivery from normal pregnant
women at MCV Hospitals, Virginia Commonwealth University Health System. Informed
consent was obtained prior to delivery. This study was approved by the Virginia
Commonwealth University Office ofResearch Subjects Protection.
In a sterile environment, the chorionic plate arteries were identified and excised
from the chorionic plate. The vessels were rinsed three times in a solution of Hank's
Balanced Salt Solution (HBSS) containing 2x strength antibiotic/antimycotic ( 100 U/mL
of penicillin, 100 µg/mL streptomycin, 25 µg/mL amphotericin B, Life Technologies,
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Long Island, NY). Next the vessels were placed in a sterile culture plate and cut
longitudinally to expose the lumen. Vessels were dissected into small pieces of tissue
(approximately 3-5 mm) and placed in a separate 100 mm culture plate with the lumen
facing down. Approximately 20 -25 explants were placed in each culture plate.
Dulbecco's Modified Essential Media (DMEM, Life Technologies, Long Island, NY)
supplemented with 10 % fetal bovine serum (FBS, Life Technologies, Long Island, NY)
(5 mL) was carefully added to the culture plate so as not to disturb adhered explants.
Culture plates were placed in a 37° C incubator (5% CO2).
Media were removed and replaced with fresh media twice a week. At this time,
culture growth and cell morphology were examined using an inverted light microscope.
Cells were observed growing from the explant within one week. At approximately two
weeks, the volume ofmedia per 100 mm culture plate was increased to 10 mL.
Cells reached confluence after approximately 4 weeks. At confluence cells were
placed in DMEM without serum for 24 hours to kill any contaminating cells, such as
fibroblasts and endothelial cells, since these cells, in contrast to smooth muscle cells, do
not survive without serum. After 24 hours, PASM cells were placed in DMEM with 10 %
FBS for trypsinization, passage or freezing according to standard protocols. PASM cells
were used between passages two and seven.

11. Verification of Vascular Smooth Muscle Cell Phenotype

Vascular smooth muscle cell phenotype for all PASM cultures (n = 5) was
verified by immunoblotting for smooth muscle myofilament proteins: a-smooth muscle
actin, f3-tropomyosin, h-caldesmon, and vinculin. Both a-smooth muscle actin and h
caldesmon are specific only to smooth muscle. The antibody for vinculin also cross
reacted with metavinculin (Sigma, St. Louis, MO). PASM cell phenotype was compared
to adult human aortic smooth muscle (HASM) cells, human intestinal smooth muscle
(HISM) cells, and HUVECs. HASM cells were kindly supplied by Dr. Gary Bowlin,
Department of Biomedical Engineering, Virginia Commonwealth University, Richmond,
VA.

a. Cell Harvesting for Western Blot

Cells were seeded in 100 mm culture plates with IO mL media (DMEM, 10%
FBS) and allowed to grow to confluence. Cells were harvested six days after the last
addition of fresh media. At confluence, the media were removed and exchanged with
DMEM without serum for 24 hours. The following day cells were harvested with a cell
scraper on ice in a sterile environment. The media were vacuumed off and the culture
plates were rinsed twice with phosphate buffered saline (PBS), pH=7.4 (Life
Technologies, Grand Island, NY). The plates were briefly scraped with a cell scraper to
enhance cell Iysing. Then 250 µL of fresh Laemmli's lysing buffer was added to the
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culture plate. The plate was scraped again and the lysate was transferred to an Eppendorf
tube with a 21-gauge needle. The cells were sheared a couple of times with the 21-gauge
needle. The sample was then placed in a -70 ° C freezer until use.

b. Gel Electrophoresis and Western Blot

In the afternoon, a 9% polyacrylamide gel was prepared Once it was determined
that there were no leaks, the gels were covered with running buffer and plastic wrap
overnight. In addition, running and blotting buffers were prepared and placed in the
refrigerator until use. The next morning a 4% polyacrylamide stacking gel was prepared.
While the stacking gel was polymerizing, the PASM lysate samples were thawed and
protein concentration was determined by measuring light absorbance at 280 nm. The
protein samples were balanced to ensure loading of equal protein concentrations to each
lane. Sample volume was equalized with buffer containing blue dye to visualize sample
migration in the gel (0.5 M Tris-HCl, 0.1 % glycerol, 10% SDS, 0.0 5% 2-methanol, and a
few grains of bromophenol blue powder) at a 1:4 ratio, respectively. A molecular weight
marker (High Range Rainbow Molecular Weight Marker, Amersham Pharmacia,
Piscataway, NJ) was prepared (8 - 10 µL of protein marker plus sample buffer equal to
sample volumes). All samples and the protein marker were then boiled for five minutes.
The samples were spun for 30 seconds, to spin down condensation due to boiling, and
vortexed. The protein marker (20 µL) was added to the left most lane and then protein
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samples (20 µL) were added from left to right. The gels were run at 165 volts for
approximately two hours or until the blue dye front migrated to the end of the gel.
To confirm equal loading of the samples, one gel was then fixed (50 mL
methanol, 10 mL acetic acid, 30 mL ddH20, I O mL fixative agent) and stained with silver
stain (Silver Stain Plus Kit, BioRad, Hercules, CA). The gel was watched closely while
developing to prevent overdevelopment. Development was stopped by placing the gel in
a 10% acetic acid solution.
The remaining gels were placed in electroblotting cassettes to transfer proteins
from the gels to nitrocellulose membranes. Each gel was placed on top ofa piece offilter
paper, which lay on a fiber pad (Trans-Blot Fiber Pads, BioRad, Hercules, CA) that was
on top of the cassette. Nitrocellulose paper was placed on top of the gel. A piece of filter
paper and a fiber pad were placed on top of the nitrocellulose paper. The cassette was
carefully closed to prevent entrapment of air bubbles and locked. Gel electrophoresis was
performed in a cold room for 2.5 hours at 65 volts. At completion, nitrocellulose
membranes were removed from cassettes and the visible protein marker was marked with
a glow-in-the-dark crayon. Membranes were blocked with a 5% solution of dry milk and
Tris buffered saline at 4 °C overnight to prevent non-specific binding.
The next morning primary antibodies were diluted at 1 : 1000 in Tris buffered
saline. Mouse monoclonal anti-human antibodies for smooth muscle myofilament
proteins were directed at: a-smooth muscle actin (IgG2a), J3 -tropomyosin (IgG), h
caldesmon (IgG) and vinculin (IgG). To ensure equal loading of protein, gels were co
stained with a housekeeping protein, a mouse IgG anti-human monoclonal antibody
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specific for 13-actin (Sigma, St. Louis, MO). The gel stained for a-smooth muscle actin
was not co-stained with 13-actin because similar molecular weights would lead to
overlapping expression and inability to compare a-smooth muscle actin expression
among cell cultures. Membranes were incubated with primary antibody for one hour on a
rotator at room temperature and followed by four 25-minute washings with Tris buffered
saline and Tween-20 (0.1 %). A goat monoclonal secondary antibody, conjugated to
horseradish peroxidase, (Roche Molecular Biochemicals, Indianapolis, IN) was diluted
1 :10 ,000 in Tris buffered saline and Tween-20 (0.1%) and incubated for one hour on a
rotator at room temperature. The nitrocellulose membranes then were washed for two
hours to remove excess secondary antibody. The wash solution (Tris buffered saline and
Tween-20) was changed eight times during the wash period. The last wash solution was
Tris buffered saline without Tween-20.
Western Lightning Chemiluminescence Reagent Plus Enhanced Luminol
(PerkinElmer Life Sciences, Boston, MA) was used to develop the horseradish
peroxidase. The membranes were incubated with 5 mL of the combined substrate for 60
seconds and then were quickly wrapped in plastic wrap, placed in a cassette, and exposed
in a dark room using Kodak autoradiography film (Hyperfilm MP, Amersham Pharmacia,
Piscataway, NJ).

C. Results
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Cells were observed growing from chorionic plate vessel explants within one
week (Figure 7). Primary cultures of PASM cells grew to confluence in approximately
four weeks. At confluence, PASM cell cultures had a uniform cell morphology that was
characterized by elongated cells in parallel rows, typical of smooth muscle cells (Figure
7). PASM cell cultures also showed evidence ofoverlapping layers forming ridges, which
is characteristic of smooth muscle cell cultures. PASM cell morphology was retained
after several passages.
All PASM cells expressed smooth muscle myofilament proteins: a-smooth
muscle actin, �-tropomyosin, h-caldesmon, vinculin and metavinculin (Figures 8-9).
PASM cultures showed similar protein expression to that of the other smooth muscle
cells, HASM and lllSM. All smooth muscle cell cultures strongly expressed a-smooth
muscle actin. PASM cells were used between passages two and five and there was no
difference in protein expression among various passages. HUVECs expressed vinculin
and �-tropomyosin, but neither of the smooth muscle-specific myofilament proteins.
Since PASM cells showed similar protein expression to HASM and lllSM cells, but not
to endothelial cells, these data indicated that cultured PASM cells were smooth muscle
cells and not contaminated with endothelial cells. All lanes had similar expression of�
actin, confirming equal protein loading.

D. Discussion

In this study, we describe a simple and economical method to obtain human
vascular smooth muscle cells for in vitro studies. Morphological and immunoblotting
evidence confirmed that the established primary PASM cell cultures were vascular
smooth muscle cells, and not contaminated with endothelial or fibroblast cells. PASM
cell smooth muscle myofilament protein expression was similar to HASM cells. Since
placentas are readily available to investigators and the health of the mother and sex ofthe
baby are easily obtained, we suggest that PASM cells are a good alternative for
expensive, commercially available vascular smooth muscle cells from adult donors. We
used these cells in the next chapter to study the effects of oxidative stress and linoleic
acid on vascular smooth muscle cell production ofIL-8 and AA metabolites.
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Figure 7.

1 Week

2 Weeks

3 Weeks

4 Weeks

PASM explant growth to establish primary cultures ofvascular smooth
muscle cells.

PASM cells were observed growing from explants within one week. Cells grew to
confluence over the next three weeks. Magnification is xl OO.

65

�<v��»._ �ri, � � �� � ..J.r<,,0 �
CJ
CJ CJ CJ CJ CJ
CJ
(�� ��� <?� <?� <?� <?� <?� '<'� '<''0 �
'?:>

t>t

220

97

66

a-smooth
muscle actin
(42 kDa)

45
----.
30

�-Tropomyosin 45
(36 & 39 kDa)
30

Figure 8.

Western blot for smooth muscle myofilament proteins.

PASM, HASM and HISM cells, but not HUVECs, expressed a-smooth muscle actin and
�-tropomyosin.
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Figure 9.

Western blot for smooth muscle myofilament proteins.

PASM, HASM and HISM cells, but not HUVECs, expressed h-caldesmon. All cells
expressed vinculin.

Chapter 3

VASCULAR SMOOTH MUSCLE CELL PRODUCTION OF IL-8 IN RESPONSE
TO OXIDATIVE STRESS AND LINOLEIC ACID

A. Introduction

In the previous chapter, we described a technique to isolate and culture human
vascular smooth muscle cells. In this chapter, we used these cells to investigate the effect
of oxidative stress and linoleic acid on vascular smooth muscle cell production of IL-8.
Oxidative stress and hyperlipidemia involving linoleic acid are present in women
with preeclampsia

1 5 • 98 • 99 .

For this reason, we wanted to determine if a combination of

oxidative stress and linoleic acid could modulate chemokine expression of the
vasculature to create an environment conducive to transendothelial migration of
neutrophils. We were specifically interested in vascular smooth muscle regulation of IL8, a potent neutrophil chemokine known to be upregulated by oxidative stress, because
vascular smooth muscle expression of IL-8 would provide a chemotactic gradient from
the circulation to the vascular smooth muscle for neutrophil infiltration. We chose
linoleic acid for our in vitro studies because linoleic acid is elevated early in pregnancy in
women destined to develop preeclampsia

98
,
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linoleic acid is increased in the diets of

women that develop preeclampsia

105 ,
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and linoleic acid is the dietary precursor for AA

and its metabolites which mediate inflammatory responses.
Previous research in our laboratory demonstrated that oxidative stress in the
presence oflinoleic acid increased IL-8 production, as well as AA metabolite production,
by human intestinal smooth muscle cells

1 5 1 • 1 52 .

We questioned if oxidative stress plus

linoleic acid also affected AA metabolite production by vascular smooth muscle cells,
and possibly played a role in IL-8 expression. If the AA pathway was involved in
vascular smooth muscle regulation of IL-8, then inhibition of AA metabolite production
should result in a decrease in IL-8 expression.
We hypothesized that oxidative stress in the presence of linoleic acid would
upregulate vascular smooth muscle expression of IL-8 and that IL-8 expression would be
linked with AA metabolites.

B. Materials and Methods

PASM cells were isolated and characterized by smooth muscle myofilament
proteins by techniques previously described (Chapter 2 ). Initially, an IL-8 time-course
was conducted and AA metabolite production was analyzed to determine that PASM
cells were functionally active.
PASM cells (passages two - seven) were suspended in DMEM, 10 % FBS and
were seeded into 24-well Costar tissue culture plates at 40,000 cells / well (Costar, Fisher
Scientific, Malvern, PA). The following day, media were discarded and replaced with
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fresh media to remove unattached cells. PASM cells grew for four days to confluence. On
the fourth day, the media were discarded and replaced with DMEM without serum.
Treatments were prepared the following day in M199 media, added for 18 hours and run
in triplicate. Five to eight experiments were performed for each treatment group. PASM
media were collected and stored at -20 °C.
Cell viability was confirmed by Trypan blue exclusion staining and MTT viability
and proliferation assay. Following collection of media, PASM cells were trypsinized,
centrifuged, and resuspended in media. A small volume of the cell suspension was
incubated with Trypan blue at a ratio of 4: 1 and counted to determine percent viability.
Trypan blue only permeates dead cells. Relative MIT concentrations were also used to
evaluate cell viability between treatment groups 1 53. MTT is a tetrazolium salt that is
cleaved by mitochondrial dehydrogenase enzymes of living cells. In the presence of an
acid-isopropanol solution, cleaved MIT will solubilize to yield a blue formazan product
that can be measured spectrophotometrically. Foil owing incubation with treatments and
collection of media, PASM cells were incubated with 0.5 mg/mL MTT dissolved in PBS
(1 mL) for four hours at 37 ° C. Cells then were incubated for 30 minutes with an acid
isopropanol solution composed of: isopropanol (45 mL), ultra pure water (5 mL), sodium
dodecyl sulfate (0.25 g), and concentrated HCl (100 µL). Fluid suspension was collected
and absorption was analyzed at 595 nm by a 96-well microplate reader (Tecan, Research
Triangle Park, NC). This assay is a measurement of viable cells since MTT is only
processed by mitochondria of living cells.
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To mimic an environment of oxidative stress, we used an oxidizing solution (Ox)
composed of: hypoxanthine (RX, 0.05 mM, Sigma, St. Louis, MO), xanthine oxidase
(XO, 0.002 units / mL, Roche Molecular BioChemicals, Indianapolis, IN), and ferrous
sulfate (FeS04, 5 µM, Sigma, St. Louis, MO). The oxidizing solution was enriched with
linoleic acid (LA, 45 µM, Cayman Chemical, Ann Arbor, MI) to mimic the
hyperlipidemic state ofpreeclampsia. We used nordihydroguaiaretic acid (NDGA, 5 µM,
Sigma, St. Louis, MO) to inhibit the LPO pathway and indomethacin (Indo, 5 µM,
Sigma, St. Louis, MO) to inhibit the COX pathway (Figure 10 ). PASM cells were treated
for 18 h with the following solutions:

1)

M l 99

2)

LA (45 µM)

3)

Ox

4)

Ox enriched with LA (OxLA)

5)

OxLA + NDGA (5 µM)

6)

OxLA + Indo (5 µM)

Media were analyzed for IL-8, and the following AA metabolites representing the
LPO pathway: leukotriene B4 (LTB4 ), and the COX pathway: prostaglandin E2 (PGE2 )
and thromboxane B2 (TXB2 ). Media were analyzed by commercially available enzyme
linked irnmunosorbant assays (ELISA) (R&D Systems, Minneapolis, MN). Data were
analyzed by one-way analysis of variance (ANOVA) and Student-Newman-Keuls post
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hoc test was used to determine differences between treatment groups. (*P<0.05,
**P<0 .01) Statistical analysis was performed using StatView software (StatView, Abacus
Concepts, Inc., Berkeley, CA).

C. Results

PASM cells spontaneously produced IL-8 while cultured in M199 media.
Concentrations ofIL-8 increased progressively during 18 h of incubation (Figure 11 ). A
culture time of18 h was chosen for all subsequent experiments. Figures 12 and 13 show
that PASM cells were viable following treatments.
PASM cells treated with OxLA produced significantly more IL-8 than M199
media, LA, or Ox (Figure 14 ). Both NDGA and Indo significantly inhibited IL-8
production induced by OxLA (Figure 15).
OxLA, but not LA, significantly increased production of LTB4 by PASM cells as
compared to M l 99 media or Ox (Figure 16). PASM cell LTB4 production was
significantly inhibited by NDGA, but not by Indo, demonstrating inhibition of the LPO
pathway (Figure 16). Both LA and OxLA significantly increased production of COX
metabolites as compared to M199 media or Ox (Figures 17 and 18). PASM cell
production of PGE2 was almost completely inhibited by lndo, but not by NDGA,
demonstrating inhibition of the COX pathway (Figure 17). Surprisingly, PASM cell
production of TXB2 was inhibited by NDGA, as well as Indo, suggesting that NDGA
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inhibits thromboxane synthase (Figure 18). This was an unexpected finding because
NDGA is described as a selective LPO inhibitor.

D. Discussion

The presence of both LA and Ox were necessary to stimulate P ASM cell
production of IL-8. Neither LA alone rior Ox alone increased IL-8 production. To
determine if AA metabolites were involved in the regulation of IL-8 production by
vascular smooth muscle cells upon treatment with OxLA, we used NDGA to inhibit the
LPO pathway and Indo to inhibit the COX pathway. Surprisingly, both NDGA and Indo
inhibited IL-8 production. This suggested that AA metabolites were involved, but it did
not differentiate between the LPO and COX pathways.
To distinguish which AA pathway mediated the IL-8 response, we measured
representative AA metabolites of each pathway after treatment with LA, Ox, OxLA, and
OxLA plus AA pathway inhibitors. OxLA, but not LA, significantly increased production
of LTB 4 as compared to M199 media or Ox. In contrast, both OxLA and LA markedly
stimulated the COX products, PG:Ei and TXB2. Ox alone did not stimulate either LPO or
COX metabolites. As expected, OxLA plus Indo inhibited PGE2 and TXB2, indicating
inhibition of COX. Unexpectedly, OxLA plus NDGA not only inhibited LTB4 indicating
inhibition ofLPO, but it also inhibited TXB2 production, indicating NDGA also inhibits
thromboxane synthase.

This unexpected finding made it more difficult to determine whether a LPO or
COX metabolite was mediating IL-8 production. For an AA metabolite to mediate IL-8
production, it must be stimulated under conditions that stimulate IL-8, and it must be
inhibited under conditions that inhibit IL-8. Since both TXB2 and IL-8 were stimulated
by OxLA and inhibited by OxLA plus NDGA and OxLA plus Indo, TXB2 may be a
mediator in IL-8 production. Experiments with specific thromboxane synthase inhibitors,
thromboxane antagonists, and thromboxane mimetics will be necessary to prove the role
of thromboxane in IL-8 production. Additional experiments with an inhibitor of LPO
more specific than NDGA, will further clarify the role ofLTB4•
We have demonstrated that the combination of Ox and LA acts on vascular
smooth muscle cells to stimulate production of IL-8 and AA metabolites. Our data
suggest that IL-8 is regulated by AA metabolites, possibly by thromboxane, under
conditions of oxidative stress. We speculate that oxidative stress and elevated levels of
LA in preeclamptic women lead to increased IL-8 and AA metabolite production by
vascular smooth muscle cells. The production of IL-8 by vascular smooth muscle would
create an IL-8 concentration gradient from the circulation to the vascular smooth muscle,
which would favor transendothelial migration of neutrophils. Since the AA metabolite,
LTB4, is also a neutrophil chemotactic agent, the production of LTB4 under conditions of
oxidative stress and hyperlipidemia involving LA would cause additional neutrophil
chemotaxis from the circulation to vascular smooth muscle. Vascular smooth muscle also
produces thromboxane in the presence of oxidative stress and LA. The production of
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thromboxane by vascular smooth muscle cells, which contain thromboxane receptors,
may be responsible for vasoconstriction leading to hypertension ofpreeclampsia.
In conclusion, oxidative stress and elevated plasma levels of LA during
preeclampsia may act on vascular smooth muscle to produce vascular inflammation
characterized by increased IL-8 and AA metabolite production, leading to neutrophil
transendothelial migration and hypertension. In Chapter 5, we will show evidence that
vascular smooth muscle express IL-8 in women with preeclampsia and that this is
associated with neutrophil infiltration into systemic vasculature.
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Inhibition ofarachidonic acid cascade by NDGA and Indo.

LA incorporates into cell membranes to form esterified AA. PLA2 releases AA from
the cell membrane so that is can be acted upon by COX or LPO to produce
prostaglandins (PGs) or leukotrienes (LTs), respectively. Thromboxane synthase
converts PGH2 into TX. We hypothesized that one ofthese AA metabolites mediates
IL-8 production by vascular smooth muscle cells. Indo inhibited COX to prevent
formation ofPGs and TX. NDGA inhibited LPO to prevent formation ofLTs. In the
course ohhis study, we found that NDGA also inhibited thromboxane synthase.
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Time course for the spontaneous production ofIL-8 by PASM cells
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Concentrations of IL-8 increased progressively during 18 h of incubation. A culture time
of 18 h was chosen for all subsequent experiments.
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Percent viability ofPASM cells following an 18 h treatment period using
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All treatment groups had a percent viability above 90 %.
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Production of IL-8 by PASM cells exposed to M 1 99, LA, Ox, or OxLA
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OxLA significantly increased IL-8 production as compared to M 1 99 media, LA, or Ox.
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Production of IL-8 by PASM cells exposed to treatments with LA, Ox,
OxLA, or OxLA with AA metabolite inhibitors for 1 8 h.

AA metabolite inhibitors (NDGA and Indo) significantly decreased IL-8 production as
compared to OxLA. *P < 0.05 (n = 5)
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Production of LIB4 by PASM cells exposed to M199, LA, Ox, OxLA, or
OxLA with AA metabolite inhibitors for 18h.

LIB4 production was significantly greater in the presence of OxLA as compared to M l 99
media control, LA, or Ox. NDGA significantly inhibited L1B4 production, whereas Indo
did not. *P < 0.05 (n = 8)
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Production ofPGE2 by PASM cells exposed to M199, LA, Ox, OxLA, or
OxLA with AA metabolite inhibitors for 18 h.

Both LA and OxLA significantly increased PGE2 production as compared to M199 media
control or Ox. Indo significantly decreased PGE2 production, whereas NDGA did not.
*P < 0.05 (n = 8)
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Production ofTXB2 by PASM cells exposed to M199, LA, Ox,
OxLA, or OxLA with AA metabolite inhibitors for 18 h.

Both LA and OxLA significantly increased TXB2 production as compared to M199
media control or Ox. AA metabolites (NDGA and Indo) significantly decreased
TXB2 production as compared to LA or OxLA. *P < 0.05 (n = 7)

Chapter 4

THE NEUTROPBIL SUPEROXIDE BURST IN REAL TIME IN RESPONSE TO
OXIDATIVE STRESS AND LINOLEIC ACID

A. Introduction

Neutrophils are activated in preeclampsia 122' 127 , but the mechanism of activation
is unclear. Research has demonstrated that oxidized lipids alter monocyte function to
increase the neutrophil 0/ burst

3
1 9.

The previous chapter demonstrated that together

oxidative stress and linoleic acid alter the expression of chemotactic agents, such as IL-8
and L TB4 , by vascular smooth muscle cells to create an environment conducive to
transendothelial migration of neutrophils. Since oxidized lipids modulate monocyte
function, we wanted to explore if an oxidizing solution enriched with linoleic acid would
alter neutrophi1 0/ production.
We used a novel chemiluminescent method to specifically measure neutrophil
0/ production in real time. Historically, ROS have been measured using a cytochrome C
assay, which measures oxygen consumption over a period of time to indicate generation
of ROS. Our methodology uses a synthesized chemiluminescent probe that specifically
interacts with O/ to produce photons of light that can be measured with a
84
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xybenzyl)-6photomultiplier. We used a synthesized analog of coelenterazine (2-(4-hydro
(4-hydroxyphenyl)-8-benzyl-3, 7-dihydroirnidazo[ l ,2-a] pyrazin-3-one), which is the
biologically active component or light-producing molecule, of bioluminescent marine
organisms. Specifically, we chose Detector "C" from the available synthesized analogs
because it had the lowest background luminescence 154· 155•
We hypothesized that the neutrophil 02·- burst would be greater in response to
oxidative stress plus linoleic acid than controls. If true, these data could explain
neutrophil activation in preeclampsia and suggest a priming mechanism for the
transendothelial migration of neutrophils.

B. Materials and Methods

1. Neutrophil Isolation

Healthy volunteers (n = 9) agreed to donate blood for the isolation of neutrophils.
Signed consent was obtained. This protocol was approved by the Office of Research
Subjects Protection, Virginia Commonwealth University. Whole blood (20 mL) was
collected by vein puncture into two 16 x 100 mm sodium heparin vacutainer tubes (VWR
Scientific Products, Pittsburgh, PA). The neutrophil isolation procedure was performed
within one hour of blood collection.
Human peripheral blood neutrophils were isolated from whole blood as described
by Boyum

1 56•

Histopaque 1 1 19 (Sigma Chemical Company, St. Louis, Missouri) was
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layered below Histopaque 1077 (Sigma Chemical Company, St. Louis, Missouri) in a 50
mL conical tube (Coming Incorporated, Coming, New York). Whole blood was slowly
layered onto the upper gradient of Histopaque 1077 (Figure 19). Toe layered blood and
Histopaque were centrifuged at 700 x g (Beckman J6-MC centrifuge, Beckman
Instruments, Inc., Columbia, MD) for 30 minutes at room temperature (25 ° C). Two
distinct layers of leukocytes were obtained; the upper layer contained monocytes,
lymphocytes and platelets, and the lower layer contained granulocytes.
The upper layers of plasma, monocytes, lymphocytes, and Histopaque 10 77 were
aspirated and discarded to within 0.5 cm of the granulocyte layer. Granulocytes were
aspirated and transferred to a new 50 mL conical vial. The granulocytes were washed to
remove any remaining Histopaque by adding sterile PBS, pH 7.4 (Life Technologies,
Grand Island, New York) and centrifuged for 10 minutes at 200 x g. PBS was aspirated
and discarded up to the cell pellet and the washing procedure was repeated.
A pellet remained which contained neutrophils and residual erythrocytes. To lyse
contaminating erythrocytes, 3 mL of ice-cold ddH20 was added and the tube gently
agitated. After exactly 30 seconds, 1 mL of ice-cold 0.6 M KCl was added to restore
tonicity. The cell suspension was centrifuged at 200 x g for 4 minutes at 4 °C to form a
white pellet containing primarily neutrophils. Approximately 96% of the cells were
neutrophils and only 4% were eosinophils and basophils.
Neutrophils were resuspended with 4 mL of Hanks' Balanced Salt Solution
(HBSS) containing no Mg

+t

+t

or Ca (Life Technologies, Grand Island, New York) and

placed in a 15 x 100 mm non-adherent Teflon tube (Minisorp, Nunc, Rochester, NY).

'o7
The Teflon tube was placed on a slant rank attached to an orbital rotator (50800 Rotomix
Rotator, Therrnolyne, Dubuque, IA) in an incubator gassed with 5% CO2 while a cell
count was performed (Forrna Scientific, Inc., Marietta, Ohio). Neutrophils were
resuspended with DMEM/F I2, 10 % FBS and returned to the incubator until the
experiment, approximately 4 hours. At the time of the experiment, cells were
resuspended to a concentration of2 x 10 6 cells/mL ofPBS.

11. Protocol for Oxidizing Linoleic Acid

Hypoxanthine (HX, 0.0 123 g for a final concentration of 3.6 mM) (Sigma
Chemical Company, St. Louis, Missouri) was added to a 50 mL conical vial containing
22.5 mL ofM199 media (Life Technologies, Grand Island, New York) and sonicated for
twenty-five minutes. Then 0.00 187 g of xanthine oxidase (XO, activity of0.067 units /
mg solid) (Sigma Chemical Company, St. Louis, Missouri) was added for a final
concentration of 0.005 units I mL. This solution was sterile filtered. A 0.02 M ferrous
sulfate (FeS04 , Sigma Chemical Company, St. Louis, Missouri) solution was made by
sterile filtering 25 mL ofddH20 and then adding 0. 139 g ofFeS04. Sixty-three µLs of the
0.02 M FeS04 solution was added to the HX / XO solution for a final concentration of 50
µM. This was our oxidizing solution (Ox).
A 0. 1 1 M solution of linoleic acid (LA) was made fresh every 3 days by diluting 1
g of LA in 33 rnL of 100% ethanol. A volume of20.5 µL of the 0.11 M solution of LA
was added to Ox to achieve a LA concentration of 90 µmo!/ L. This was followed by
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addition of 2.5 mL FBS (heat-inactivated) for a total volume of 25 mL. XO generates
02.- during metabolism ofHX to uric acid. LA in the Ox solution was oxidized by 02·- in
++

the presence of Fe

according to the Fenton reaction. We determined an optimum

concentration for XO (0.0 5 units I mL) for 02·- production from previous experiments.
This was our Ox solution enriched with LA (OxLA).
To compare the neutrophil 02·- burst upon stimulation with OxLA, we also
stimulated neutrophils with known activators including, phorbol 12-myristate acetate
(PMA, 8 µg/mL) and lipopolysaccharide (LPS, 100 ng/mL). Stock solutions of activators
were prepared and an appropriate volume of stock solution was added to I mL of Ml 99
to equal the final concentration noted above. This solution then was injected into the
measuring tube.
To confirm cell viability, cell counts for Trypan blue uptake were performed
following measurement of neutrophil 02·-.

111.

Superoxide Measurement

The 0 2·- chemiluminescent measuring system was designed to directly measure
02·- production, as photons of light, from tissue maintained in a physiological
environment (Figure 20 ). The measuring instrument was constructed to be virtually light
tight by Tom Gentry, Biomedical Engineering Department, Virginia Commonwealth
University. Cells remained at 37 ° C and 95% air and 5% CO2 using circulating warm
water and appropriate gas tanks ( 15 psi). The photomultiplier tube was maintained at
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-30 C by a LCT50 control unit with circulating cool water and was powered by a high
voltage power unit set for 1000 volts. Photons of light were measured and the data were
transmitted to a ctl counter timer computer program for analysis.
Neutrophils (500 µL, 2 x 106 cells / mL) were placed into a Teflon tube in a light
tight and thermostatically insulated chamber. Detector "C" (2 µL, 25 µM), the
coelenterazine analog, was then added to the cell suspension. The sample was placed in
the measuring chamber and covered with the measuring chamber cap containing
treatment and gas injection tubes. Finally, the cap was secured with wing nuts to form a
light-tight and thermostatically insulated chamber.
For control purposes, counts began with the photomultiplier shutter closed and the
voltage source set for O volts. Initial counts were zeros. Upon enabling the voltage source
to relay 1 000 volts, the counts showed background noise. After several data counts, we
opened the shutter to obtain baseline counts, which represented spontaneous 0/
production from unstimulated neutrophils. Injections consisted of 500 µl of oxidizing
solution enriched with linoleic acid (90 µM). Since the injection was added to 500 µL of
cell suspension, the final concentration of OxLA was 45 µM. OxLA injections were
followed by an injection of oxidizing solution, which contained hypoxanthine, xanthine
oxidase, and ferrous sulfate, for control purposes. Superoxide dismutase (Sigma, St.
Louis, MO) was added following treatments to confirm that we were measuring 0/
anions and not artifact. The experiment concluded by repeating control steps in the
opposite sequence: 1 ) the shutter was closed to measure background noise, and 2) the
high voltage source was shut off. Data collection ended when counts were zeros.
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C. Results

OxLA caused an immediate dose-dependent increase in photon counts,
representative of 02 ·-production (Figure 2 1). Superoxide production upon stimulation
with OxLA ranged from 2 10 - 764.4 picomoles. Injection of SOD caused an immediate
decline in photon counts, verifying that we were measuring 02 ·-. Figure 22 shows
decreased photon counts when OxLA was injected into the measuring chamber in the
absence of neutrophils. These photon counts represented 02·- produced by our Ox
solution, and confirmed that the 02 ·- burst observed in the previous figure was from
neutrophils, rather than Ox solution. In contrast to OxLA, LA or Ox alone did not induce
a neutrophil superoxide burst (Figure 23).
Upon injection with OxLA, 02 ·- production peaked within 20 seconds and then
declined to baseline with a half-life of 120 seconds (Figure 24). LPS caused a slower rise
time in 0/- production as compared to OxLA (3 minutes vs. 20 -30 seconds) (Figure 25).
Treatment with PMA induced a slower rise time in 02.- production similar to LPS (data
not shown).

D. Discussion

We measured the neutrophil 02 .- burst upon stimulation with OxLA in real time
using a novel chemilumiscent 02.- measuring system. OxLA rapidly stimulated
neutrophil 02·- production. In contrast, neither Ox nor LA stimulated 02 ·- production by
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neutrophils. Neutrophil 02 - production upon stimulation with OxLA differed from
stimulation with LPS or PMA. LPS and PMA produced gradual increases in 02·
production, whereas stimulation with OxLA lead to a rapid and more intensive burst of
0/-.
In conclusion, OxLA was a potent and immediate stimulator of neutrophil 02.
production. These data suggest that oxidative stress and elevated plasma levels of LA
may be responsible for neutrophil activation in preeclamptic patients. This could
contribute to the clinical symptoms ofpreeclampsia. Activated neutrophils would release
0/ and other ROS to propagate and exacerbate oxidative stress within the maternal
vasculature. Transendothelial migration of activated neutrophils with production of ROS
could oxidize lipid membranes and damage endothelial cells and vascular smooth muscle
cells. In addition, generation of TNFa, MPO, and TX by neutrophils could cause
inflammation of the vasculature and vasoconstriction. Systemic oxidative stress would
favor neutrophil transendothelial migration by stimulating IL-8 and LIB4 production by
vascular smooth muscle cells (Chapter 3) and by increasing 02°-production by
neutrophils.
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1 077
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Figure 1 9.

Neutrophil isolation from whole blood by histopaque density gradient
separation.

Whole blood was layered upon two densities of histopaque. Centrifugation caused
leukocytes to separate into layers by density, so that granulocytes (neutrophils) could
be collected for experiments.
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Figure 20.

Superoxide chemilwninescent measuring system.

Neutrophils were placed into the Teflon measuring tube, which was placed into the
measuring chamber. The measuring chamber was sealed with the measuring chamber
cap. Treatments were injected through the treatment injection tube. The
photomultiplier tube measured photons in real time. Photon counts were recorded by a
computer and then transferred to Excel software for processing.
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Figure 2 1.

Neutrophil superoxide production upon stimulation with OxLA.

OxLA caused an immediate dose-dependent increase in neutrophil superoxide
production. Superoxide dismutase (SOD) caused an immediate decline in photon
counts verifying that we were measuring superoxide.
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Injections of OxLA into the measuring chamber without neutrophils.

This graph illustrates that the superox.ide burst observed in the previous figure was
from neutrophils rather than oxidizing solution.
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Comparison ofneutrophil superoxide burst upon stimulation with
OxLA, LA, and Ox.

In contrast to OxLA, LA or Ox alone did not induce a neutrophil superoxide burst.
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Figure 24.

Time-course of neutrophil superoxide burst caused by OxLA.

OxLA caused an immediate increase in neutrophil superoxide production, which
peaked within 20 seconds and then declined to baseline with a half-life of 120
seconds. As in the previous figure, Ox alone did not induce a superoxide burst by
neutrophils.

98

(/)

:cQ. 4000000 ..------------------------�

-e

:::::,
Q)

Z 3000000 +-------------�------"""""�----t

CD
0
T""

X

-

T""

- 2000000 +---------,Jr."'-----_:_::::,-..,-______

C

:::::,

0

o 1000000 +---C
0
0

..c
a..

___----I-J

ioxLA

(/)

----1--

----

---

---

--

--

------'

0 +---�--�-�--�-�--�----�-----'
31

61

91

Time ( 1 0 second intervals)
Figure 25.

Time-course comparison ofthe neutrophil superoxide burst with OxLA
as compared to LPS, a neutrophil activator.

LPS ( 100 ng/mL) caused a slower rise time in superoxide production than OxLA (3
minutes vs. 20 -30 seconds). Similar to LPS, PMA (8 µg/mL) also produced a slower
rise time in superoxide production (data not shown).

Chapter 5

INFILTRATION OF NEUTROPHILS INTO SYSTEMIC VASCULAR TISSUE
IN WOMEN WITH PREECLAMPSIA
IN ASSOCIATION WITH INCREASED EXPRESSION OF
ENDOTHELIAL ICAM-1 AND VASCULAR SMOOTH MUSCLE CELL IL-8

A. Introduction

The previous chapters explored the relationship between oxidative stress,
hyperlipidemia, and vascular cell dysfunction using in vitro models. These studies
demonstrated increased vascular smooth muscle cell production of IL-8 and increased
neutrophil 0 2·- production upon treatment with oxidative stress and linoleic acid. These
data suggested a mechanism for neutrophil transendothelial migration in preeclampsia
based on neutrophil activation and vascular smooth muscle production of IL-8.
Neutrophil infiltration into vascular tissue requires at least three things: 1)
vascular expression of a chemotactic agent to attract neutrophils, 2) endothelial
expression of adhesion molecules to bind neutrophils to the endothelium, and 3)
neutrophil activation. Therefore, to study if neutrophils infiltrate vascular tissue in
women with preeclampsia, we used immunohistochemistry with specific antibodies to
99

1 00
evaluate: 1 ) vascular smooth muscle expression of IL-8, 2) endothelial expression of
ICAM-1, and 3) neutrophil activation and infiltration into systemic vascular tissue. We
used subcutaneous fat biopsies for this study because subcutaneous fat is a highly
vascularized tissue representative ofthe systemic vasculature.
We evaluated IL-8 because it is a potent chemotactic agent and activator of
neutrophils. IL-8 activates neutrophils to enhance their chemotaxis, integrin expression,
and respiratory burst activity during inflammation. IL-8 is upregulated in the presence of
oxidative stress

144

,

and our previous in vitro experiments demonstrated that exposing

vascular smooth muscle cells to oxidative stress and linoleic acid resulted in increased
production of IL-8. Therefore, we reasoned that there would be increased expression of
IL-8 by vascular smooth muscle in preeclampsia. This would provide a concentration
gradient from the circulation to the vascular smooth muscle for neutrophil
transendothelial migration.
We evaluated endothelial expression of ICAM-1 because it is an adhesion
molecule that binds integrins (CD11 b/CD18) on the neutrophil surface causing them to
adhere and flatten onto the endothelium prior to infiltration. Stimuli similar to that for IL8 increase ICAM-1 expression, such as oxidative stress. ICAM-1 is elevated in the
plasma of preeclamptic women
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•

and ICAM-1 is upregulated upon treatment of

HUVECs with plasma from preeclamptic women

1 12

,

suggesting a role for ICAM-1 in the

pathogenesis ofpreeclampsia.
We evaluated neutrophils in preference of other leukocytes because: 1) they are
the most abundant of the leukocytes, 2) their numbers increase in pregnancy 1 , 3) their
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numbers further increase in preeclampsia 1 , and 4) they produce toxic substances (ROS,
MPO, TX and TNFa), which could be responsible for vasoconstriction and vascular cell
dysfunction in women with preeclampsia.
We hypothesized that in women with preeclampsia there would be increased
expression of vascular smooth muscle IL-8 and endothelial ICAM- 1 coincident with
infiltration of neutrophils into maternal systemic vascular tissue. Figure 26 is a schematic
representation ofour hypothesis.

B. Materials and Methods

i. Study Subjects

Subcutaneous fat biopsies were collected from patients at MCV Hospitals,
Virginia Commonwealth University Health System. Fat biopsies were collected at the
time of cesarean section from normal pregnant patients (n = 6) and preeclamptic patients
(n = 5) or at the time of abdominal or minimally invasive surgery from normal, non
pregnant patients (n = 4 ). Cesarean sections for normal pregnant women were performed
because of previous c-section or secondary to latent herpes simplex virus or fetal
malposition. Surgeries for normal non-pregnant women were performed for removal of
uterine myomas (fibroids) or for tissue biopsies. The criteria for normal pregnancy were a
maternal blood pressure of less than 140/90 mmHg, no proteinuria, non-smoker, and no
other complications. The diagnosis of preeclampsia was based on ACOG
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recommendations. Mild preeclampsia was defined as hypertension greater than 140/90
mm.Hg on at least two separate measurements six hours apart and proteinuria greater than
300 mg/24 hours or 1-2 plus dipstick. Severe preeclampsia was defined as hypertension
greater than 160/110 mmHg and proteinuria greater than 5,000 mg/24 hours or 3-4 plus
dipstick. One preeclamptic patient had gestational diabetes, which was diet controlled.
Preeclamptic women were non-smokers. Women in active labor were excluded from the
study. The criteria for normal, non-pregnant patients were a blood pressure of less than
140/90 mmHg, non-smoker, and no systemic inflammatory conditions, such as diabetes.
Patients were matched for BMI. Informed consent was obtained prior to surgery. This
study was approved by the Virginia Commonwealth University Office of Research
Subjects Protection.

u. Collection ofFat

Subcutaneous fat biopsies (approximately 1 cm x 1 cm x 1 cm) were collected at
cesarean section or abdominal or minimally invasive surgery. In the operating room fat
biopsies were snap-frozen in liquid nitrogen or placed immediately in 10 % neutral
buffered formalin. The tissue was further processed in the laboratory. Frozen tissue was
wrapped in aluminum foil and stored at -70 ° C until tissue processing. Formalin-fixed
samples were cut into smaller pieces, placed in tissue cassettes and returned to 10 %
neutral buffered formalin for five days. Fixation was confirmed by observation and touch.
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Formalin-fixed samples were rinsed in ddH20 and placed in 100 mM phosphate buffer,
pH=7.5 until paraffin-embedding.

iii. Protocol for Frozen Tissue

Frozen tissue was used to perform immunohistochemical staining for IL-8. At the
time of sectioning, a frozen biopsy was cut into smaller pieces and allowed to equilibrate
to -30 ° C in a cryotome (Leica CMl l OO, Leica Microsystems Inc., Allendale, NJ). A
small amount of frozen tissue matrix (Tissue-Tek O.C. T. Compound, VWR, Pittsburgh,
PA) was placed on the cryotome chuck. As the matrix began to freeze, a piece of frozen
tissue was placed on top and covered slowly with additional matrix. Once frozen, the
mounted tissue was cut in 20 µm sections and placed on Superfrost Plus microscope
slides (Fisher Scientific, Pittsburgh, PA). Slides were warmed quickly to room
temperature by pressing the slide against the palm of a gloved hand and fixed in cold
acetone (-20 ° C) for three minutes. Slides were air-dried and placed in a -70 °C freezer
until staining.
On the day of staining, slides were warmed rapidly to room temperature by
pressing the slide against the palm of a gloved hand and placed immediately in I 00 mM
phosphate buffer saline (0 .9% NaCl), pH=7.5 for ten minutes. To quench endogenous
tissue peroxidase, tissue sections were blocked with 0.3% H202 in methanol for ten
minutes followed by a five minute wash in phosphate buffered saline.
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The ABC technique was used for immunohistochemical staining. This
methodology is based on the binding of a preformed avidin and biotin horseradish
peroxidase macromolecular complex to a biotinylated antibody, which is bound to the
primary antibody and antigen of interest. Visualization was produced by a buffered H202
and chromogen, 3,3 '-diaminobenzidine tetrahydrochloride (DAB), solution.
Immunohistochemical staining was performed at room temperature using
VECTASTAIN Elite ABC (Universal} and DAB Substrate Kits (Vector Laboratories,
Burlingame, CA) with a ST 5050 automated staining machine (Vision Instruments,
Australia). Every step was strictly controlled for each antibody. Each step of the staining
cycle was followed by a rinse with phosphate buffered saline (PBS) + 0.05% Tween-20
(3 rinses; 5 minutes) (Gibco, Long Island, New York). For IL-8 staining, all solutions
were prepared in I OOmM PBS, pH=7.5, except for DAB substrate solution which was
prepared in Grade 1 ultrapure H20. For ICAM-1 and CD66b staining, except for DAB
substrate solution, all solutions were prepared in l OOmM phosphate buffer, pH=7.5.
In preparation for staining, slides were covered briefly with PBS + 0.05% Tween20 , pH=7.4 (Gibco, Long Island, New York). Tissue was blocked with horse serum
blocking solution for 20 minutes. Tissue was stained with a mouse IgG anti-human
monoclonal antibody specific for IL-8 (1 :50 , BioSource International, Camarillo, CA).
The negative control for IL-8 was a mouse IgG monoclonal isotype standard (pre-diluted,
Zymed Laboratories, San Francisco, CA). To confirm intact endothelium and identify
vascular smooth muscle, tissue was imrnunostained with a rabbit anti-human monoclonal
antibody directed at Factor VIII (1:600 , Zymed Laboratories, San Francisco, CA) and a
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mouse anti-human monoclonal antibody directed at a-smooth muscle actin ( 1 :6000 ,
Sigma, St. Louis, MO). Their staining also was used to identify vessels and determine the
location of IL-8, ICAM- 1 , and CD66b staining. Next the tissue sections were covered
with biotinylated antibody (anti-mouse/anti-rabbit IgG made in horse) for 30 minutes.
The enzyme conjugate (Vectastain ABC reagent) was incubated on the tissue for 30
minutes. The protein-antibody complex was localized with a DAB substrate chromogen
mixture for five minutes.
Tissue was counterstained with filtered alcian blue stain, pH=2.5 ( 1 % alcian blue
dye + 3% acetic acid) for five minutes followed by rinsing in tap H 20 1 57. Slides then
were dipped in methyl green (Vector Laboratories, Burlingame, CA), placed on a metal
tray, and incubated for three minutes in a 60 °C oven. Sections were rinsed in Grade 1
ultrapure water for one minute and dipped five times in 0.05% acetic acid in acetone.
Sections were dehydrated (50%, 85%, 95%, 95%, 100%, 100%; 2 minutes each) and
cleared two times for 3 minutes in Histoclear (National Diagnostics, Atlanta, Georgia).
Slides were mounted with VectaMount (Vector Laboratories, Burlingame, CA) and
covered with a coverslip.

1v. Protocol for Formalin-fixed Tissue

Formalin-fixed tissue was used for ICAM- 1 and CD66b staining. Tissue was
dehydrated in a graded alcohol series (70%, 80%, 95%, 95%, 100%, 100%, 100 %),
cleared in CitriSolv (Fisher Scientific, Malvern, PA), and paraffin-embedded overnight
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using an automated tissue processor (Shandon Citadel 2000 Tissue Processor, Shandon
Scientific Limited, Cheshire, England). The next day paraffin-embedded tissue was
placed in embedding rings and covered with additional paraffin.
Tissue was cut in 8 µm sections using a microtome (820 Spencer Microtome,
American Optical Company). Sections were floated on a preheated 42 ° C ddH20 bath
(Flotation Bath Model 135, Fisher Tissue Prep, Fisher Scientific, Malvern, PA), separated
into tissue sections of three, and placed on Superfrost Plus glass slides (Fisher Scientific,
Malvern, PA). Slides were dried on a 37° C slide warmer (C.S. & E Slide Warmer No.
26020, Clinical Scientific Equipment Co., Melrose Park, Illinois), and then placed in a
37°C oven overnight.
On the day of staining, tissue sections were cleared three times with Histoclear
(National Diagnostics, Atlanta, Georgia) to remove paraffin (five minutes each) and then
hydrated in a graded alcohol series (100%, 100%, 95%, 95%, 85%, 50 %, 0 %; two
minutes each). Tissue sections were placed in 100 mM phosphate buffer, pH=7.5 for ten
minutes. To quench endogenous tissue peroxidase, the tissue was blocked with 0.3%
H202 in methanol for 30 minutes followed by washes in 100 mM phosphate buffer,
pH=7.5 (5 minutes) and Grade 1 ultrapure water (6 minutes).
Antigen retrieval was performed with microwave citrate pretreatment. Five slides
were placed upright in a polypropylene Coplin jar filled with citrate buffer (10 mM; pH =
6.0 ) and microwaved at 90 ° C for 10 minutes at 70 % power. Slides remained in the
covered container for 30 minutes, at which time they were transferred to 100 mM
phosphate buffer, pH=7.5 for a minimum of five minutes prior to staining.
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Tissue was incubated for 30 minutes with a primary antibody. Primary antibodies
included: 1) a mouse IgG anti-human monoclonal antibody against ICAM-1 (CD54,
1:100 , Zymed L aboratories, San Francisco, CA), 2) a mouse IgG monoclonal isotype
standard used as a negative control for ICAM-1 (pre-diluted, Zymed Laboratories, San
Francisco, CA), 3) a mouse IgM anti-human monoclonal antibody specific for CD66b
( 1:500, BD BioSciences, San Diego, CA), and 4) a mouse IgM monoclonal isotype
standard used as a negative control for CD66b ( 1:500, BD BioSciences, San Diego, CA).
CD66b is a granulocyte-specific glycosylphosphatidylinositol-linked membrane antigen
that is upregulated and released upon granulocyte activation. CD66b is involved in
granulocyte phagocytosis, cell adherence, and chemotaxis 1 58 and it promotes adhesion of
granulocyte �2 integrins (CD1 l b/CD18) to endothelial cells 1 59• 1 60 . Thus, CD66b staining
not identified granulocytes, but diffuse CD66b staining also indicated secretion by
activated granulocytes. Granulocytes from a normal non-pregnant individual were
isolated by density centrifugation and used as a positive control for CD66b. Isolated
monocytes and lymphocytes were used as negative controls. Granulocytes are comprised
of neutrophils, eosinophils and basophils. Neutrophils comprise 96% of the granulocyte
population. In addition, neutrophils respond to tissue inflammation, whereas eosinophils
and basophils respond to parasitic diseases and various forms of allergy. Therefore, our
data primarily represent neutrophils.
Tissue sections also were stained with a rabbit IgG anti-human antibody specific
for Factor VIII ( 1 :400) and a mouse IgG anti-human antibody directed at a-smooth
muscle actin (1:3000 ). To increase cross-reactivity between primary and secondary
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antibodies, since CD66b was an IgM, the concentration ofthe biotinylated antibody (antimouse/anti-rabbit IgG made in horse) was doubled. Slides were incubated for 30 minutes.
The remainder of the staining methodology for formalin-fixed tissue was identical to that
for frozen tissue.

v. Data Analysis

To quantify staining, an observer unaware of the patient' s identity scanned the
middle tissue section of each slide in a systematic manner. Lumen width was measured
for each vessel and vessels were categorized as small (:Sl O µm), medium (10 µm-39 µm)
or large (�40 µm). Vessels between 10 µm and 200 µm, which represent resistance-sized
vessels, were analyzed for staining. For each patient, approximately 34 vessels were
evaluated for IL-8 staining and 92 vessels for ICAM-1 staining. Vessels staining for IL-8
and ICAM- 1 were graded using a visual score ranging from zero to four (from absent to
intense) and also were evaluated by density measurements using image analysis software
(Image Pro Plus, Media Cybernetics, Silver Spring, MD). The visual score was correlated
to density measurements to verify objectivity ofthe visual score.
For CD66b staining, an average of 126 vessels were analyzed for each patient.
Each vessel was graded using a visual score ranging from zero to four based on overall
staining intensity and neutrophil infiltration. Since the CD66b protein is secreted from
activated neutrophils, diffuse staining for CD66b also was evaluated for staining density
using image analysis software. In addition to visual scores and density measurements,
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CD66b staining of neutrophils was recorded as present within the lumen, along the
endothelium, within the inti.ma and vascular smooth muscle, and present on the outside of
the vessel wall. The number ofstained neutrophils was counted in each of these locations.

v1. Statistical Analysis

Kruskal-Wallis and Chi square were used to analyze visual score data for staining.
Frequency distributions were completed for visual scores. For density measurements,
one-way ANOVA was performed and Student-Newman-Keuls post-hoc test was used to
determine differences between the patient groups. Regression analysis was performed to
correlate visual scores with density measurements. Bar graph data are reported as mean ±
SE.
For CD66b staining data, statistical analysis also was performed for the percent of
vessels with staining in certain vessel locations: 1) along the endothelium, 2 ) within the
inti.ma, and 3) on the outside of the vessel, and for the number of infiltrated neutrophils
per stained vessel. ANOVA was performed and Student-Newman-Keuls post-hoc test
was used to analyze differences between patient groups. Kruskal-Wallis and Dunn's post
hoc test were used when variances were not equal. Bar graph data are reported as mean ±
SE.

C. Results

1.

1 10

Subjects

The clinical data for normal non-pregnant, normal pregnant, and preeclamptic
groups are summarized in Table 3. According to criteria, systolic and diastolic blood
pressures and proteinuria were significantly greater for preeclamptic patients than for
other groups. The preeclamptic group also was characterized by significantly lower
parity, gestational age, and infant birth weight as compared to normal pregnant patients.
Maternal age was not significantly different between normal pregnant and preeclamptic
groups, and there was no difference in BMl among groups.

11. Immunohistochemical Staining

Vessels of preeclamptic patients had intense IL-8 staining, whereas normal
pregnant patients and normal non-pregnant patients had light or no IL-8 staining (Visual
score: 2.8 ± 0. 1 vs. 0.7 ± 0. 1 vs. 0.7 ± 0. 1, respectively, P<0.00 1 , Figure 27). Optical
density (OD) measurements confirmed that preeclamptic patients had significantly
greater IL-8 staining as compared to normal pregnant or normal non-pregnant patients
(126.0 ± 3.7 OD vs. 70.2 ± 2.4 OD vs. 67.5 ± 2.8 OD, respectively, P<0.00 1 , Figure 28).
Chi square analysis verified higher visual scores for preeclamptic patients (P<0.000 1 )

111
. (Figure 29). The visual scores were highly correlated with the density measurements, r =
0.99 (Figure 30).
Preeclamptic patients had intense IL-8 staining in vascular smooth muscle cells,
as well as in endothelial cells. In contrast, normal pregnant patients had light IL-8
staining in endothelial cells and vascular smooth muscle cells, and normal non-pregnant
patients had little or no IL-8 staining of the vessel (Figure 3 1). Figure 32 shows intense
staining for IL-8 in the vascular smooth muscle of preeclamptic patients, which is
verified by co-localization ofa-smooth muscle actin.
ICAM- 1 was constitutively expressed in all groups. The visual scores for ICAM- 1
staining were greater for preeclamptic patients than normal pregnant or normal non
pregnant patients (2.5 ± 0. 1 vs. 1.9 ± 0.2 vs. 2.2 ± 0. 1, respectively, P<0.05, Figure 33).
Although the visual scores for ICAM-1 staining were statistically significantly greater for
preeclamptic patients than normal pregnant or normal non-pregnant patients, the
difference in staining was minimal and probably does not reflect physiological
differences. The density measurements also showed that ICAM- 1 expression was
constitutive among all groups. Preeclamptic patients had more intense staining for
ICAM-1 as compared to normal pregnant patients, but less staining than normal non
pregnant patients ( 1 16.7 ± 2.9 OD vs. 96.9 ± 7.8 OD vs. 136.2

±

3. 1 OD, respectively,

P<0.0 1, Figure 34). Chi square analysis indicated higher visual scores for preeclamptic
patients (P<0.000 1) (Figure 35). There was a strong correlation between visual scores and
density measurements, r = 0.95 (Figure 36).
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In women with preeclampsia, ICAM- 1 staining was present not only on the
endothelium, but also on the vascular smooth muscle (Figures 37 and 38). Although there
was ICAM- 1 staining of endothelium and vascular smooth muscle in normal pregnant
women, the staining was not as intense, nor as diffuse, as in preeclamptic women (Figure
37). Staining for ICAM- 1 was localized to endothelium of normal non-pregnant women
(Figure 3 7).
A visual score, representing intensity of CD66b staining, as well as quantity of
neutrophil infiltration, was significantly greater for preeclamptic than normal pregnant
patients or normal non-pregnant patients ( 1.9 ± 0.0 7 vs. 0.3 ± 0.0 3 vs. 0.3 ± 0. 1,
respectively, P<0.0 1, Figure 39). The visual score was verified by density measurements,
which also indicated more intense CD66b staining for preeclamptic patients as compared
with normal pregnant patients or normal non-pregnant patients ( 126 ± 2 OD vs. 68 ± 2
OD vs. 75 ± 5 OD, respectively, P<0.0 1, Figure 40). Chi square analysis indicated higher
visual scores for preeclamptic patients (P<0.000 1) (Figure 4 1). There was a strong
correlation between visual scores and density measurements, r = 0.90 (Figure 42).
The percentage of vessels stained for CD66b was significantly greater for
preeclamptic patients than normal pregnant patients or normal non-pregnant patients (76
± 8% vs. 27 ± 7% vs. 23 ± 6%, respectively, P<0.0 1, Figure 43). Of these vessels, there
was greater staining for CD66b in the preeclamptic patients in all vessel locations, except
in the lumen. In preeclamptic patients as compared with normal pregnant patients and
normal non-pregnant patients, there was greater adherence and flattening of neutrophils
along the endothelium (55 ± 7% vs. 19 ± 6% vs. 15 ± 4%, respectively, P<0.0 5, Figure
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44), infiltration into the inti.ma (52 ±11% vs. 6 ± 2% vs. 2 ± 1%, respectively, P<0.01,
Figure 45) and number of neutrophils on the outside of the vessel (26 ± 7% vs. 3 ± 1 %
vs. 2 ± 2%, respectively, P<0.05, Figure 46). The total number ofneutrophils adhered to
endothelium, infiltrated into inti.ma, and present on the outside of the vessel per stained
vessels was also greater for preeclamptic patients than normal pregnant patients or
normal non-pregnant patients (7.3 ± 0.8 vs. 1.9 ± 0.4 vs. 1.3 ± 0.3 per 8 µm section of
vessel, respectively, P<0.001, Figure 47). Table 4 summarizes these data.
CD66b specific staining of neutrophils was verified by staining of leukocytes
isolated by Histopaque density centrifugation of whole blood. CD66b stained neutrophils,
but not monocytes or lymphocytes (Figure 48). Representative sections of vessels are
shown for CD66b staining of neutrophils in normal non-pregnant patients, pregnant
patients, and preeclamptic patients (Figure 48). Figure 49 shows representative examples
of neutrophil adherence and flattening on to endothelium, infiltration into the inti.ma, and
presence outside of the vessel wall of vessels from women with preeclampsia.

D. Discussion

Staining for IL-8, a potent neutrophil chemotactic agent, was significantly greater
in preeclamptic women as compared to normal pregnant or normal non-pregnant women.
IL-8 staining was observed on vascular smooth muscle, in addition to endothelium, in
women with preeclampsia. This finding is significant because it demonstrates
inflammation of vascular smooth muscle in preeclampsia. Increased expression of
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vascular smooth muscle IL-8 in preeclampsia establishes a concentration gradient for IL8 from the circulation to the vascular smooth muscle. Since neutrophils migrate along a
concentration gradient to IL-8
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,

these data provide a mechanism for transendothelial

migration ofneutrophils to the vascular smooth muscle in preeclampsia
Vascular ICAM-1 expression was significantly greater in preeclamptic patients
than normal pregnant or normal non-pregnant patients. ICAM- 1 was constitutively
expressed on the endothelium in all groups, but in preeclamptic patients ICAM-1 was
expressed intensely on vascular smooth muscle as well as on endothelial cells. This is
further evidence, corroborating the IL-8 data, that there is inflammation of vascular
smooth muscle in preeclampsia. Increased endothelial ICAM- 1 expression provides
evidence that endothelial cells are a likely source ofelevated plasma levels of ICAM- 1 in
.
.
.
.
preeclampsia, as reported by other mvestlgators 83' 84' 162. They are also consistent WI"th an
in vitro study that demonstrated increased endothelial cell ICAM- 1 expression upon
incubation with preeclamptic plasma 1 12.
The percentage of vessels stained for CD66b was significantly greater in women
with preeclampsia than in nonnal pregnant or normal non-pregnant women. There were
significantly more neutrophils adhered and flattened along the endothelium, within the
intima and present on the outside of the vessel wall in women with preeclampsia as
compared to controls. The percentage of neutrophils present within different portions of
the vessel correlated with an overall greater number of neutrophils per vessel. Diffuse
vessel staining also was present in women with preeclarnpsia and, most likely, reflects
secretion of CD66b from activated neutrophils.
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These new data may explain previous findings in the field of preeclampsia. A

study by Roggensack et al. showed increased expression of nitrotyrosine, suggestive of
ONOO- formation, a strong prooxidant, in the vasculature of women with preeclampsia
1 1 0.

A simultaneous increase in the expression ofendothelial NOS and a decrease in the

expression of SOD also were observed. Our findings may explain the source of 0/- for
the formation ofONOO- because the rapid interaction of neutrophil 02·- with endothelial
NO• in the presence of deficient SOD would produce ONOO-. Our data in conjunction
with Roggensack' s data strongly suggest that there is localized systemic oxidative stress
throughout the maternal vasculature, which results in vascular lipid peroxidation leading
to vascular inflammation and dysfunction.
Chappell et al. reported that vitamin E and vitamin C supplementation
significantly decreased the incidence of preeclampsia in women at increased risk 48. A
decrease in the incidence of preeclampsia was associated with a decrease in urinary
isoprostane, a marker of oxidative stress 49 . These data implicate oxidative stress in the
pathogenesis of preeclampsia by using antioxidants to prevent development of the
disorder. Since oxidative stress upregulates many components involved in neutrophil
transendothelial migration, the prophylactic use of antioxidants during pregnancy may
inhibit mechanisms involved in transendothelial migration of neutrophils to prevent
development of preeclampsia.
Neutrophil adherence and infiltration were evident in resistance-sized vessels.
Neutrophils are known to produce thromboxane, a potent vasoconstrictor, in the presence
ofoxidative stress

163 .

Hypertension, therefore, may result as activated neutrophils deliver
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thromboxane directly to the vascular smooth muscle. Vascular disruption and oxidative
stress caused by the products of adhered and infiltrated neutrophils would also affect
endothelial cell integrity to proteins 1 64, resulting in edema in the systemic circulation and
proteinuria in the kidney.
In summary, the present study is the first to provide in vivo evidence of vascular
smooth muscle inflammation and neutrophil infiltration into maternal systemic vascular
tissue in preeclampsia. These new data suggest that there is total "vascular cell
dysfunction", which includes vascular smooth muscle cells, in addition to endothelial
cells, in preeclampsia. These data could explain the clinical symptoms of hypertension,
proteinuria, and edema, and they suggest novel treatments for preeclampsia based on
neutralizing antibodies to IL-8 or cell adhesion molecules.
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Figure 26.

Vascular Smooth Muscle

A visual representation of our hypothesis of increased expression of
vascular smooth muscle IL-8 and endothelial ICAM- 1 coincident
with infiltration of neutrophils into maternal systemic vascular tissue
in women with preeclampsia.

Activated neutrophils adhere and flatten onto endothelial cells by binding to ICAM1 . In response to IL-8 produced by vascular smooth muscle cells, neutrophils
infiltrate into the intimal space. We speculate that neutrophil production of ROS,
MPO or TX could result in vasoconstriction and vascular dysfunction.
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Table 3.

Clinical data for patient groups.
Normal Nonpregnant
(n = 4)

Normal
Pregnant
(n = 6)

Maternal Age

38.5 ± 5.4

27.5 ± 4.5

24.6 ± 5.5 +

Pre-pregnancy BMI

3 1.8 ± 4.4

26.6 ± 6.5

29.2 ± 7.9t

126.0 ± 9.2

119.5 ± 12.6

178.0 ± 12.8**

79.3 ± 9.2

76.7 ± 8.2

111.0 ± 12.3 ......

Proteinuria (mg / 24 h)

ND

ND

Dipstick

ND

ND

Parity

NA

2.8 ± 1.2

1.2 ± 1. 1 *

Gestational Age (wk)

NA

39. 1 ± 0.8

33.7 ± 3.8**

Infant Birth Weight (g)

NA

3291 ± 533.8

2004 ± 1027*

Systolic Blood Pressure
(mm Hg)
Diastolic Blood Pressure
(mm Hg)

Preeclamptic
(n- 5)

885 ± 374.8
(n = 2)
3.7 ± 0.6
(n = 3)

Values are mean ± SD. ND indicates not determined. NA indicates not applicable.
*P<0.05, * *P<O.O I compared with normal pregnant or normal non-pregnant.
+ indicates no difference between preeclamptic and normal pregnant.
t indicates no difference among groups.
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Summarized visual score results for IL-8 staining.

Preeclamptic patients had significantly greater IL-8 staining as compared to normal
non-pregnant or normal pregnant patients. The visual score for preeclamptic patients
reflected staining of both vascular smooth muscle cells and endothelial cells, whereas
the visual scores for normal non-pregnant and normal pregnant reflected staining
primarily of endothelial cells. ***P < 0.00 1 (NNP = 1, NP = 4, PE = 3)
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NNP
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Summarized density measurements for IL-8 staining.

Density ofIL-8 staining in preeclamptic patients was significantly greater than in
normal non-pregnant or normal pregnant patients. *** P < 0.00 1 (NNP = 1, NP = 4,
PE = 3)
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Figure 29.

Frequency distributions of visual scores for IL-8 staining.

Preeclamptic patients had more vessels with higher visual scores for IL-8 staining
than normal non-pregnant or normal pregnant patients. x2 < 0.000 1
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Figure 30.

Correlation between visual scores and density measurements for IL-8
staining.

There was a positive correlation (r = 0.99) between visual scores and density
measurements. These data show that visual scoring was objective and precise.
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A

IL-8 immunohistochemical staining ofvessels in subcutaneous fat.

a) IgG negative control, x600, b) Normal non-pregnant patient showing no vessel
staining, x300, c) Normal pregnant patient showing light brown vessel staining,
x300, d) Preeclarnptic patient showing intense brown vessel staining, x600.
(A- adipocyte, VL- vessel lumen, VW- vessel wall)
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Figure 32.

IL-8 immunohistochemical staining (panels a and c) contrasted with
staining for a-smooth muscle actin (panels b and d) in preeclamptic
patients.

IL-8 staining is clearly evident in the vascular smooth muscle ofthese preeclamptic
patients. The longitudinal arrangement ofthe vascular smooth muscle is evident by
IL-8 staining in panel c. a) IL-8, x600 , b) a-smooth muscle actin, x600 , c) IL-8,
x400, d) a-smooth muscle actin, x400.
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Swnmarized visual score results for ICAM-1.

ICAM- 1 was constitutively expressed in all groups. Preeclamptic patients had
significantly greater ICAM-1 staining as compared to normal non-pregnant or normal
pregnant patients, primarily due to staining in vascular smooth muscle cells, as well as
endothelial cells. There was no difference for ICAM-1 staining between normal non
pregnant and normal pregnant patients. *P < 0.05
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NNP
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Summarized density measurements for ICAM-1.

Density ofICAM-1 staining in preeclamptic patients was significantly greater than in
normal pregnant patients and significantly less than in normal non-pregnant patients.
Staining in normal non-pregnant patients was limited to the endothelium, whereas in the
normal pregnant patients and especially in the preeclamptic patients, staining was present
in vascular smooth muscle, as well as endothelium. Density measurement, as opposed to
visual score, did not reflect the spread of staining to vascular smooth muscle cells.
**P < 0.0 1
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Figure 35.

Frequency distributions of visual scores for ICAM- 1 staining.

Preeclamptic patients had more vessels with higher visual scores for ICAM-1
staining than normal non-pregnant or normal pregnant patients. x2 < 0.000 1
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Figure 36.

Correlation between visual scores and density measurements for
ICAM- 1 staining.

There was a positive correlation (r = 0.95) between visual scores and density
measurements. These data show that visual scoring was objective and precise.
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ICAM- 1 staining ofvessels in subcutaneous fat.

a) IgG Negative control, x400 , b) Normal non-pregnant patient showing brown
staining of the endothelium lining the vessel lumen, but not of the vascular smooth
muscle. Leukocytes also express ICAM- 1 and some are stained in the lumen (thin
arrows), x30 0 , c) Normal pregnant patient showing brown staining ofthe
endothelium, as well as light staining ofthe vascular smooth muscle, x600 , d)
Preeclamptic patient showing intense brown staining ofendothelium, as well as
vascular smooth muscle, x400.
(EC- endothelial cells, VSMC- vascular smooth muscle cells)
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Figure 38.

Comparison of staining for ICAM-1 (panel b) with staining for
Factor VIII delineating endothelium (panel a) and staining for a
smooth muscle actin delineating vascular smooth muscle (panel
c) in a preeclamptic patient.

Staining for ICAM- 1 is clearly evident in the vascular smooth muscle, as well as
in the endothelium, x400.
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Summarized visual score results for CD66b staining.

Preeclamptic patients had significantly greater CD66b staining as compared to
normal non-pregnant or normal pregnant patients. The visual score for CD66b
was based on both staining intensity and quantity ofneutrophil infiltration.
***P < 0.00 1
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Summarized density measurements for CD66b staining.

Density of CD66b staining was significantly greater for preeclamptic patients as
compared to normal non-pregnant or normal pregnant patients. * **P < 0 .00 1
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Figure 41.

Frequency distributions of visual scores for CD66b staining.

Preeclarnptic patients had more vessels with higher visual scores ofCD66b staining than
normal non-pregnant or normal pregnant patients. x2 < 0.000 1
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Figure 42.

Correlation between visual scores and density measurements for
CD66b staining.

There was a positive correlation (r = 0.90) between visual scores and density
measurements. These data show that visual scoring was objective and precise.
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Percent ofvessels stained with CD66b.

A mean of76% ofthe vessels in preeclamptic patients stained for CD66b as compared to
27% for normal pregnant patients and 23% for normal non-pregnant patients. **P < 0.01
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Percent ofvessels with neutrophils adhered and flattened onto
endothelial cells.

Over halfof the vessels ofpreeclamptic patients had neutrophils adhered and
flattened to the endothelium as compared to 19% for normal pregnant patients and
15% for normal non-pregnant patients. **P < 0 .0 1
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Percent ofvessels with neutrophils infiltrated into the intimal space.

Over 50 % ofthe vessels of preeclamptic patients showed neutrophil infiltration to
the intima as compared to 6% for normal pregnant patients and 2% for normal non
pregnant patients. *** P < 0.00 1
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Percent of vessels with neutrophils present on the outside of the vessel.

Twenty-six percent of the vessels of preeclamptic patients had neutrophils present on
the outside of the vessel as compared to 3% for normal pregnant patients and 2% for
normal non-pregnant patients. **P < 0.01
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Average number ofneutrophils adhered and flattened onto
endothelium, infiltrated into intima space, and present on the outside
of the vessel for a 8 µm section oftissue.

The average number of neutrophils per vessels with staining was 7.3 for preeclamptic
patients as compared to 1.9 for normal pregnant patients and 1.3 for normal non
pregnant patients. Neutrophil staining for normal non-pregnant and normal pregnant
patients primarily involved only endothelial cell adherence, whereas neutrophil
staining for preeclamptic patients involved all aspects ofthe vessel. ***P < 0.00 1
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Table 4.

Summary of CD66b imm unohistochemical staining for resistance
sued vessels (10 µm - 200 µm)
Normal NonPregnant
{n = 4}

Normal
Pregnant
{n = 6}

Preeclamptic
(n = 5)

Total Vessels with Stained Cells

22.6 ± 6. 1%

26.9 ± 7.5%

76.6 ± 8.4%**

Vessels with Stained Cells Adhered
& Flattened on Endothelium

14.8 ± 4.2%

18.5 ± 6.2%

55.9 ± 6.9%**

Vessels with Stained Cells in
Intima

2.3 ± 1.0 %

6.5 ± 2.2%

52.3 ± 10.6%***

Vessels with Stained Cells on
Outside ofVessel

2.5 ± 2.2%

3.0 ± 1.4%

26.0 ± 6.6%**

No. ofNeutrophils / Vessel with
7.3 ± 0.8***
1.9 ± 0.4
1.3 ± 0.3
Staining (8 µm section)
Values represent mean ± SEM. *P < 0.05, **P < 0.0 1, ***P < 0.00 1 compared with
normal pregnant and normal non-pregnant.
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Figure 48.

CD66b staining of leukocytes (panels a and b) and of vessels in
subcutaneous fat (panels c-t).

a) Neutrophils isolated from blood showing brown staining for CD66b, x600, b)
Monocytes and lymphocytes isolated from blood showing lack of staining for
CD66b, x600, c) IgM negative control, x400, d) Normal non-pregnant patient
showing no CD66b staining, x400, e) Normal pregnant patient showing a rounded
cell lightly stained for CD66b on the endothelium (arrow), x600, t) Preeclamptic
patient showing massive brown staining for CD66b along the endothelium and in the
intima, x600.

142

b

5011111

� 1-----

.. ,.
d

Figure 49.

Representative sections of CD66b staining of neutrophils in various
vessel locations in preeclamptic patients.

a) This section shows brown stained neutrophils within the lumen and along the
endothelium. In the upper part of the vessel are two examples of neutrophils adhered
and flattened onto the endothelium (arrows), x600, b) This vessel shows massive
neutrophil involvement. Neutrophils are adhered to the endothelium and present
within the intima. The entire circumference of the vessel is involved, x600, c) This
vessel is an example of neutrophil staining in the intima (arrows), x900, d) This
vessel also shows massive neutrophil involvement Neutrophil staining is clearly
evident on the outside of the vessel (arrows), x900.

Chapter 6

DISCUSSION

This investigation is the first to demonstrate neutrophil transendothelial migration
into systemic vascular tissue in women with preeclampsia. It also suggests how
transendothelial migration of neutrophils may be favored in an environment of oxidative
stress and elevated levels of linoleic acid by activation of neutrophils and vascular
smooth muscle expression of IL-8. The observations of this dissertation link vascular
smooth muscle, endothelial, and neutrophil dysfunction to a single mechanism,
transendothelial migration of neutrophils, that could explain the clinical symptoms of
preeclampsia of hypertension, proteinuria, and pathological edema.
Oxidative stress and elevated plasma levels of linoleic acid are present in women
with preeclampsia. Our in vitro data indicated that this combination favors a mechanism
for neutrophil transendothelial migration. Specifically, our studies demonstrated that
treatment of vascular smooth muscle cells with an oxidizing solution enriched with
linoleic acid, but not either component alone, led to increased vascular smooth muscle
cell production ofIL-8. Similarly, this treatment solution rapidly activated neutrophils to
produce superoxide. This favors neutrophil transendothelial migration because increased
expression of IL-8 by vascular smooth muscle would create a concentration gradient for
143
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IL-8 from the circulation to vascular smooth muscle to attract neutrophils, and rapid
activation of neutrophils would prime them for transendothelial migration. The final
study confirmed the predictions of the in vitro studies by demonstrating vascular smooth
muscle cell expression of IL-8 coincident with neutrophil infiltration into systemic
vascular tissue in women with preeclampsia. Inflammation of the vascular smooth
muscle, as well as endothelium, was evident by expression of both IL-8 and ICAM- 1 in
women with preeclampsia.
Although there is little reason to believe that vasculature supplying subcutaneous
fat differs from other systemic vasculature, it would be of interest to confirm neutrophil
transendothelial migration in other systemic tissues, such as muscle or skin. This could be
done in future experiments by taking small pieces ofskin and abdominal muscle from the
abdominal incision.
Another future investigation of our laboratory will be to determine the
relationship between the degree of neutrophil infiltration and the severity of clinical
symptoms of preeclampsia. We were unable to do this in the present study because the
sample size was too small. However, analysis of samples from women with hemolysis,
elevated liver enzymes and low platelets (HELLP) syndrome, considered a severe form
of preeclampsia by many clinicians, provided some information regarding the
relationship between neutrophil activity and clinical symptoms. Our patient group with
HELLP had blood pressures characteristic of severe preeclampsia, but proteinuria levels
characteristic of mild preeclampsia. Vessels of HELLP women had less neutrophil
infiltration as compared to our preeclampsia group, which was composed primarily of
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severe preeclamptics, suggesting that the degree of neutrophil infiltration was correlated
with the severity of proteinuria (Figure 50). These observations suggest that as the
number of vessels with neutrophil infiltration into the intima increase, so does the
severity of proteinuria and clinical presentation. Future investigations in our laboratory
intend to clarify the relationship between neutrophil involvement and disease severity.
We plan on increasing our sample size to differentiate between mild and severe
preeclampsia. We expect to observe a linear relationship between the level of neutrophil
involvement and the progression of preeclampsia. We also plan to increase our sample
size for HELLP patients to clarify ifHELLP truly is a severe form ofpreeclampsia or is a
distinct pathophysiological process.
Our sample population did not include any women with eclampsia, which is
diagnosed when grand mal seizures accompany symptoms of preeclampsia. Ifneutrophil
activation and transendothelial migration in the systemic circulation are responsible for
clinical symptoms of preeclampsia, maybe a similar pathology in cerebral blood vessels
is responsible for seizures of eclampsia. Belfort et al. proposed that increased cerebral
perfusion pressure might cause eclamptic seizures in women with severe preeclampsia
165 .

The work of this dissertation would support this hypothesis because neutrophil

adherence and infiltration of cerebral blood vessels, accompanied with production of
ROS, would lead to increased vascular permeability, cerebral edema and increased
cerebral pressure. This idea could be tested in an animal model of preeclampsia, in which
a brain biopsy could be obtained to determine if neutrophils infiltrate cerebral blood
vessels.
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Magnesium sulfate is the present treatment to prevent progression ofpreeclampsia
to eclampsia. The mechanism of action of magnesium sulfate, however, is disputed and
not understood

1 66 .

Our data demonstrating neutrophil infiltration into systemic vascular

tissue in women with preeclampsia may explain how magnesium sulfate prevents
eclampsia. Neutrophil function and activation is modulated by magnesium. Magnesium
deficiency increases neutrophil phagocytosis and ROS production in a rat model, whereas
magnesium sufficiency inhibits neutrophil activation
using human neutrophils

168

.
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.

These results were confirmed

Another group showed a 70 % decrease in plasma

glutathione associated with neutrophil activation in magnesium deficient rats

1 69 .

Decreased plasma glutathione levels indicate systemic oxidative stress. Magnesium
sulfate for the prevention of eclampsia may act by inhibiting neutrophil activation, and
subsequently, minimize oxidative stress and reduce neutrophil transendothelial migration
of cerebral vessels. The findings of this dissertation also would explain why magnesium
sulfate is significantly more effective at preventing seizures of eclampsia compared to
.
. .
mmodtpme, a cerebral d"l
I ator 170.
During the course of our research we found evidence of neutrophil involvement
and infiltration in normal pregnant and non-pregnant patients. Upon investigation of their
medical records, we found that normal pregnant women with neutrophil infiltration were
in labor when the biopsy was collected. Non-pregnant women with neutrophil
involvement were found to be obese or obese and hypertensive. In laboring women as
compared to non-laboring women, there were significantly more vessels with staining for
neutrophils, and neutrophils flattened and adhered to the endothelium, infiltrated into the
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intima, and adhered to the outside of the vessel (Figures 51 and 52). In obese women or
obese women with hypertension, there was greater neutrophil vessel involvement than in
non-obese women with normal blood pressures (Figure 53). These observations invite
speculations regarding a role for neutrophils and neutrophil transendothelial migration in
many normal, as well as abnormal physiological processes, and suggest future research
directions.
We could speculate that parturition is an inflammatory process mediated by
neutrophils. Neutrophils infiltrate the myometrium during labor, and the number of
neutrophils present in the lower uterine segment increases with cervical dilatation 1 7 1 • 1 72 .
Increased expression of cell adhesion molecules and IL-8 with parturition indicates a
mechanism for transendothelial migration of neutrophils into these tissues

1 72 • 1 7 3
.

Neutrophils infiltrated into the myometrium may be responsible for the production of
prostaglandins and thromboxane that cause myometrial contractions. Neutrophils within
the lower uterine segment may release matrix metalloproteinases to cause cervical
ripening. Systemic vascular neutrophil activation and transendothelial migration during
labor may demonstrate a significant role for neutrophils in the process of parturition.
These data also may answer why preeclampsia is associated with preterm labor.
We could also speculate as to why neutrophil numbers increase and infiltrate
systemic tissue during labor. Neutrophils may have a protective role in case of post
partum infection. This may explain why the infection rate is so low after vaginal delivery
with episiotomy (0.35%) as compared to C-section (2%)

1 • 1 74
.

It is remarkable that

women who have completed the laboring process are less likely to develop post-partum
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infections, despite the unsterile conditions ofvaginal delivery. This may be explained by
the activation and systemic infiltration of neutrophils with labor that provide an
immediate defense to any infection. A rise in neutrophil numbers and activation during
labor is not harmful to most women, but some women may not be able to withstand the
vascular insult. This may explain why some women with normal pregnancy develop
preeclampsia in the post-partum period.
Our preliminary evidence for neutrophil activation and infiltration in obese and
obese, hypertensive women are fascinating, especially considering the similarities in risk
factors, pathology, and clinical symptoms between preeclampsia and cardiovascular
disease. Cardiovascular disease, as preeclampsia, is characterized by endothelial cell
dysfunction, oxidative stress, and generalized low-grade inflammation. Essential
hypertension and preeclampsia share clinical symptoms of hypertension and proteinuria
(microalbuminuria in the case of hypertension). Essential hypertension is unexplained
hypertension caused by an increase in total peripheral resistance. A few recent studies
have investigated a role for leukocytes, namely neutrophils, in the pathology of
cardiovascular disease and essential hypertension. For example, increased white blood
cell counts were shown to be strong predictors of coronary artery disease and stroke in
post-menopausal women, and neutrophil count and neutrophil elastase were significantly
elevated in subjects with essential hypertension

1 7 5• 1 7 6

.

Neutrophils from patients with

essential hypertension were more adhesive than neutrophils from normotensive
individuals

1 77,

as were neutrophils isolated from spontaneously hypertensive rats, which

also exhibited neutrophil-mediated cytotoxicity to endothelial cells

1 78

.

Another study
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used scanning electron microscopy to demonstrate neutrophil adhesion to endothelial
cells and invasion of endothelial cell junctions of cerebral vessels in hypertensive rats.
The evidence suggests a role for neutrophils in the pathology of essential hypertension,
but no one has demonstrated significant neutrophil involvement in systemic vasculature
as shown by our preliminary data.
Our findings suggested that one of the risk factors for essential hypertension,
obesity, is associated with increased vascular neutrophil involvement as compared to
individuals of normal weight. In obese women, there were increased numbers of vessels
with staining for neutrophils, and increased numbers ofneutrophils adhered and flattened
to endothelium, but not increased numbers infiltrated into the intima (Figures 52 and 53).
The physical presence of increased numbers of neutrophils adhered and flattened onto
endothelium would increase total peripheral resistance and could partly explain essential
hypertension. The production of vasoconstrictors, such as TX and ROS, by activated
neutrophils also could cause hypertension. It is evident that obesity shows early signs ofa
pathological process that will likely worsen over time and eventually may cause essential
hypertension. These preliminary data for obese and hypertensive women suggest that
preeclampsia may be a temporary, but an extreme and accelerated form of the
pathological process responsible for essential hypertension.
The work presented in this dissertation, demonstrating a role for oxidative stress,
elevated levels of linoleic acid and neutrophil transendothelial migration in the
pathophysiology of preeclampsia, offers numerous options for preventive and therapeutic
benefits. These findings can serve as rationale for dietary modifications or therapeutic
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targets. Dietary modification would be a simple and inexpensive method to reduce the
risk of preeclampsia. A diet low in omega-6 fatty acids and high in antioxidants prior to
and throughout pregnancy would offset oxidative stress associated with pregnancy and,
hopefully, prevent preeclampsia. This dissertation work showed that neutrophil activation
and vascular smooth muscle production of IL-8 are enhanced by oxidative stress in the
presence of linoleic acid, suggesting that if one could decrease oxidative stress,
preeclampsia could be prevented or its severity lessened. Since linoleic acid is a
polyunsaturated fatty acid and readily oxidizes, it causes lipid peroxidiation, which
propagates oxidative stress. Linoleic acid is the primary constituent of most vegetable
oils. Substitution of oils rich in oleic acid, such as olive oil, could substantially reduce
one's intake of linoleic acid. Research in our laboratory demonstrated that oleic acid, a
monounsaturated fatty acid, reduces lipid peroxidation 1 52. Dietary modifications to
decrease oxidative stress and the risk of preeclampsia are supported by the research of
Chappell et al.

48 49
' ,

who demonstrated that vitamin E and C supplementation in women

at high-risk for preeclampsia led to decreased markers of oxidative stress and a lower
incidence ofpreeclampsia.
Our observations also suggest that neutralizing antibodies to IL-8 or cell adhesion
molecules might prevent or stop the progression ofpreeclampsia Recently, a monoclonal
antibody directed against a 4 integrins showed positive outcomes for the treatment of
Crohn's Disease and multiple sclerosis in two large clinical trials

1 7 9' 180 .

Neutralizing

antibodies to IL-8, ICAM-1, or CDl 1/CD 18 would block the process of neutrophil
transendothelial migration. This treatment could prevent production of ROS, MPO, and
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TX by neutrophils present within the intima, which we speculate results in vascular cell
damage and vasoconstriction.
Another potential pharmacological intervention suggested by the results of this
dissertation would be the use of AA metabolism inhibitors, such as aspirin, to reduce
vascular inflammation and inhibit neutrophil transendothelial migration. Our in vitro data
suggested that inhibition ofthromboxane synthase would decrease production of IL-8 by
vascular smooth muscle cells in the presence of oxidative stress and linoleic acid. A
decrease in IL-8 production would reduce the chemotactic gradient for neutrophil
transendothelial migration. The suggestion to use aspirin to prevent preeclampsia is not
novel. Many small clinical studies showed that treatment with low-dose aspirin in women
at high risk for preeclampsia reduced the incidence ofpreeclampsia

1 8 1 - 184

.

However, two

large clinical studies by the National Institute of Child Health and Human Development
Network of Maternal-Fetal Medicine Units did not demonstrate a beneficial effect with
low-dose aspirin, although patient compliance was low

185 • 186 .

These unfavorable results

lead to a recommendation against low-dose aspirin for the prevention of preeclampsia.
The debate over treatment of preeclampsia with low-dose aspirin is not over. Recently, a
meta-analysis of clinical trials using aspirin to prevent preeclampsia demonstrated that
aspirin was beneficial in preventing preeclampsia 1 87 .
These preventive modifications and therapeutic agents may also be beneficial in
preventing essential hypertension. Dietary modifications of decreasing linoleic acid and
increasing oleic acid with antioxidant supplementation would decrease available
substrates for AA metabolism and inhibit oxidative stress, respectively. These
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adj ustments would inhibit many aspects of the mechanism of transendothelial migration
ofneutrophils.
In conclusion, this investigation demonstrated transendothelial migration of
neutrophils into systemic vascular tissue in women with preeclampsia. In vitro studies
complemented this observation, suggesting aspects of this mechanism, involving vascular
smooth muscle cells, endothelial cells, and neutrophils, that are modified by oxidative
stress and linoleic acid to favor neutrophil transendothelial migration. These new data
provide evidence for total ''vascular cell dysfunction" that could explain the clinical
symptoms ofpreeclampsia. It is our hope that this work is beneficial to understanding the
pathophysiology and the eventual treatment ofpreeclampsia. AMEN.
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Figure 50.

....

CD66b staining in vessels for HELLP patients.

HELLP patients (n = 3) were similar to preeclamptic patients with respect to percent of
vessels with staining (panel a) and percent of vessels with neutrophiJs adhered and
flattened onto endothelium (panel b). HELLP patients, who did not have as severe of
proteinuria as the preeclamptic patients, did not have the same degree of neutrophils
infiltrated into the intima (panel c). Panel d shows a vessel with a massive number of
brown stained neutrophils adhering to the endothelium and occluding the lumen in a
HELLP patient, x600. *P < 0.05, **P < 0.01
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CD66b staining in vessels for laboring patients.

Laboring patients (n = 3) were similar to preeclamptic patients with respect to percent of
vessels with staining (panel a) and percent ofvessels with neutrophils adhered and
flattened onto endothelium (panel b). Laboring patients, however, did not have the same
degree ofneutrophils infiltrated into the intima (panel c). *P < 0.05, **P < 0.0 1
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Figure 52.

Representative sections of CD66b staining of neutrophils in vessels of
laboring patients.

a) This section shows brown staining for neutrophils adhered to endothelium, x600, b)
This vessels shows a vessel occluded with neutrophils, x600, c) This vessel shows
massive neutrophil involvement. The entire endothelium is lined with neutrophils, x400,
d) This vessel has dark brown staining of neutrophils accumulated along the endothelium,
x600.
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NNP

NP

PE

CD66b staining in vessels for obese and hypertensive patients.

Obese (n = 1) and obese, hypertensive (n = 2) patients were similar to preeclamptic
patients with respect to percent of vessels with staining (panel a) and percent ofvessels
with neutrophils adhered and flattened onto endothelium (panel b). Obese patients,
however, did not have the same degree of neutrophils infiltrated into the intima as
compared to preeclamptic patients (panel c ). These preliminary data may explain why
obesity is a risk factor for preeclampsia, as well as essential hypertension.
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Figure 54.

Representative section ofCD66b staining ofneutrophils in a vessel ofan
obese patient.

This longitudinal section shows massive brown staining of neutrophils throughout the
length of the vessel, x400.
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